STOCK TITAN

Nocera flags going-concern doubt with $1.02M cash

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Nocera, Inc. (NCRA) reported third-quarter net sales of $2,155,280, versus $1,509,971 a year earlier, and gross profit of $454,862 versus $44,457. Net loss narrowed to $1,160,046 from $1,511,650. Electronic Components Trading generated $1,554,728 of quarterly sales. For the first nine months, sales were $6,572,628 versus $7,529,938, and net loss was $3,975,095 versus $2,095,961.

Cash and cash equivalents were $1,020,689 at September 30, 2026, after $2,471,276 in operating cash use over nine months. The company reported an accumulated deficit of $30,163,566 and said these conditions raise substantial doubt about its ability to continue as a going concern within one year; management concluded that doubt had not been alleviated.

Previously issued 2024 and 2025 annual statements and the 2025 first-, second- and third-quarter statements should no longer be relied upon because of identified errors. Nocera also reported selling approximately 231 acres in Alabama for $700,000, with an approximately $178,000 loss, and regaining Nasdaq minimum-bid-price and stockholders’ equity compliance.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 3 points

How the balance works

Positive

  • Moderate pointThird-quarter sales rose to $2,155,280 from $1,509,971.
  • Moderate pointQuarterly net loss narrowed to $1,160,046 from $1,511,650.

Negative

  • Major pointNine-month net loss widened to $3,975,095 from $2,095,961.
  • Major pointManagement said substantial doubt about one-year going-concern ability remains.
  • Moderate pointNine-month revenue fell to $6,572,628 from $7,529,938.

Filing Explained

The $100 million facility remains unused, while the completed QMAX transaction has already added 300,000 shares and diluted existing holders.

The May 22 Equity Purchase Facility Agreement gives Nocera the option, over 24 months, to sell up to $100 million of newly issued common stock to an investor. At September 30, it had sent no advance notice, issued no shares under the facility, and received no proceeds. If exercised, those sales would increase the share count and reduce existing holders’ percentage ownership.

Without stockholder approval, aggregate facility issuances are capped at 19.99% of shares outstanding on the agreement date; investor ownership is capped at 4.99%, adjustable to 9.99% after 61 days’ notice. The July 8 Form S-3 registers up to 7,500,000 facility shares for resale; registration does not mean those shares have been sold.

Separately, on July 28, Nocera issued 300,000 common shares for contractual voting and economic rights tied to a seller’s 30% QMAX stake; the seller kept registered legal title, and Nocera says it does not control or consolidate QMAX. That completed share issuance increased the common share count and reduced existing holders’ percentage ownership.

Third-quarter net sales $2,155,280 Three months ended September 30, 2026; $1,509,971 in 2025
Third-quarter gross profit $454,862 Three months ended September 30, 2026; $44,457 in 2025
Third-quarter net loss $1,160,046 loss Three months ended September 30, 2026; $1,511,650 loss in 2025
Nine-month net sales $6,572,628 Nine months ended September 30, 2026; $7,529,938 in 2025
Nine-month net loss $3,975,095 loss Nine months ended September 30, 2026; $2,095,961 loss in 2025
Operating cash flow $2,471,276 cash used Nine months ended September 30, 2026
Cash and cash equivalents $1,020,689 As of September 30, 2026
Accumulated deficit $30,163,566 As of September 30, 2026
going-concern basis financial
"prepared on a going-concern basis"
substantial doubt financial
"raise substantial doubt about the Company’s ability to continue"
equity method financial
"accounts for its investment under the equity method"
An equity method investment is an accounting approach used when a company owns enough of another business to influence its decisions but not control it (commonly around 20–50% ownership). Instead of counting only dividends, the investor records its share of the other company’s profits and losses on its own income statement and adjusts the investment’s value on the balance sheet—like tracking a friend’s joint project by noting your share of their gains or setbacks. For investors, this matters because it can significantly affect reported earnings, asset values, and the apparent strength of a company’s financial results.
variable interest entity financial
"QMAX is a variable interest entity"
A variable interest entity (VIE) is a company structure where one party controls another company’s operations and economic outcomes through contracts or special arrangements instead of owning a majority of its voting shares. For investors, VIEs matter because the controlling party’s financial results, debts and risks can appear in the controller’s reports even though ownership looks separate, so understanding VIEs helps assess true exposure, governance limits and transparency—like spotting a puppet controlled by strings rather than direct ownership.
Level 3 financial
"classified as Level 3 within the fair value hierarchy"
Level 3 describes the lowest-confidence category in the accounting “fair value” hierarchy, covering assets or liabilities whose prices are not observable in the market and must be estimated using judgment and internal models. For investors, Level 3 items matter because they can introduce greater uncertainty and potential valuation swings—like valuing a unique antique versus checking a price tag on a supermarket shelf—so they signal higher model risk and lower liquidity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were NCRA’s third-quarter 2026 sales and net loss?

NCRA reported net sales of $2,155,280 and a net loss of $1,160,046 for the three months ended September 30, 2026. The comparable 2025 quarter showed net sales of $1,509,971 and a net loss of $1,511,650.

Which financial statements did NCRA say should no longer be relied upon?

NCRA said its annual financial statements for the years ended December 31, 2024 and December 31, 2025, and its interim statements for the quarters ended March 31, June 30 and September 30, 2025, should no longer be relied upon because of identified errors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 2026 Q3 0001756180 3 3 0 3 0001756180 2026-01-01 2026-09-30 0001756180 2026-11-16 0001756180 2026-09-30 0001756180 2025-12-31 0001756180 us-gaap:SeriesBPreferredStockMember 2026-09-30 0001756180 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001756180 us-gaap:SeriesAPreferredStockMember 2026-09-30 0001756180 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001756180 2026-07-01 2026-09-30 0001756180 2025-07-01 2025-09-30 0001756180 2025-01-01 2025-09-30 0001756180 2024-12-31 0001756180 2025-09-30 0001756180 NCRA:MezzanineEquityMember 2024-12-31 0001756180 us-gaap:CommonStockMember 2024-12-31 0001756180 us-gaap:PreferredStockMember 2024-12-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-12-31 0001756180 us-gaap:RetainedEarningsMember 2024-12-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-12-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-12-31 0001756180 NCRA:MezzanineEquityMember 2025-12-31 0001756180 us-gaap:CommonStockMember 2025-12-31 0001756180 us-gaap:PreferredStockMember 2025-12-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-12-31 0001756180 us-gaap:RetainedEarningsMember 2025-12-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-12-31 0001756180 us-gaap:NoncontrollingInterestMember 2025-12-31 0001756180 NCRA:MezzanineEquityMember 2026-03-31 0001756180 us-gaap:CommonStockMember 2026-03-31 0001756180 us-gaap:PreferredStockMember 2026-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2026-03-31 0001756180 us-gaap:RetainedEarningsMember 2026-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2026-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2026-03-31 0001756180 2026-03-31 0001756180 NCRA:MezzanineEquityMember 2026-06-30 0001756180 us-gaap:CommonStockMember 2026-06-30 0001756180 us-gaap:PreferredStockMember 2026-06-30 0001756180 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001756180 NCRA:StatutoryAndOtherReservesMember 2026-06-30 0001756180 us-gaap:RetainedEarningsMember 2026-06-30 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2026-06-30 0001756180 us-gaap:NoncontrollingInterestMember 2026-06-30 0001756180 2026-06-30 0001756180 NCRA:MezzanineEquityMember 2025-01-01 2025-09-30 0001756180 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001756180 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-01-01 2025-09-30 0001756180 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-09-30 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-01-01 2025-09-30 0001756180 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-09-30 0001756180 NCRA:MezzanineEquityMember 2026-01-01 2026-03-31 0001756180 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001756180 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2026-01-01 2026-03-31 0001756180 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2026-01-01 2026-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001756180 2026-01-01 2026-03-31 0001756180 NCRA:MezzanineEquityMember 2026-04-01 2026-06-30 0001756180 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001756180 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001756180 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001756180 NCRA:StatutoryAndOtherReservesMember 2026-04-01 2026-06-30 0001756180 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-01 2026-06-30 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2026-04-01 2026-06-30 0001756180 us-gaap:NoncontrollingInterestMember 2026-04-01 2026-06-30 0001756180 2026-04-01 2026-06-30 0001756180 NCRA:MezzanineEquityMember 2026-07-01 2026-09-30 0001756180 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001756180 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001756180 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001756180 NCRA:StatutoryAndOtherReservesMember 2026-07-01 2026-09-30 0001756180 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2026-07-01 2026-09-30 0001756180 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0001756180 NCRA:MezzanineEquityMember 2025-09-30 0001756180 us-gaap:CommonStockMember 2025-09-30 0001756180 us-gaap:PreferredStockMember 2025-09-30 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-09-30 0001756180 us-gaap:RetainedEarningsMember 2025-09-30 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-09-30 0001756180 us-gaap:NoncontrollingInterestMember 2025-09-30 0001756180 NCRA:MezzanineEquityMember 2026-09-30 0001756180 us-gaap:CommonStockMember 2026-09-30 0001756180 us-gaap:PreferredStockMember 2026-09-30 0001756180 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001756180 NCRA:StatutoryAndOtherReservesMember 2026-09-30 0001756180 us-gaap:RetainedEarningsMember 2026-09-30 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2026-09-30 0001756180 us-gaap:NoncontrollingInterestMember 2026-09-30 0001756180 2026-07-31 0001756180 2026-07-05 2026-07-06 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001756180 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2026-09-30 0001756180 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-12-31 0001756180 NCRA:QMAXVIEAgreementsMember 2026-09-30 0001756180 NCRA:PrepaidExpensesMember 2026-09-30 0001756180 NCRA:PrepaidExpensesMember 2025-12-31 0001756180 NCRA:OtherAssetMember 2026-09-30 0001756180 NCRA:OtherAssetMember 2025-12-31 0001756180 NCRA:AdvancesToSuppliersMember 2026-09-30 0001756180 NCRA:AdvancesToSuppliersMember 2025-12-31 0001756180 us-gaap:LandMember 2026-09-30 0001756180 us-gaap:LandMember 2025-12-31 0001756180 us-gaap:EquipmentMember 2026-09-30 0001756180 us-gaap:EquipmentMember 2025-12-31 0001756180 2026-08-07 0001756180 2026-08-06 2026-08-07 0001756180 NCRA:TachyonextIncMember 2025-06-05 0001756180 NCRA:TachyonextIncMember 2025-06-04 2025-06-05 0001756180 NCRA:TachyonextIncMember 2026-07-01 2026-09-30 0001756180 NCRA:TachyonextIncMember 2026-01-01 2026-09-30 0001756180 NCRA:TachyonextIncMember 2026-09-30 0001756180 NCRA:TachyonextIncMember 2025-12-31 0001756180 NCRA:TachyonextIncMember 2025-01-01 2025-12-31 0001756180 NCRA:LONGWOOLMember 2025-12-02 0001756180 NCRA:LONGWOOLMember 2025-11-29 2025-12-02 0001756180 NCRA:LONGWOOLMember 2026-07-01 2026-09-30 0001756180 NCRA:LONGWOOLMember 2026-01-01 2026-09-30 0001756180 NCRA:LONGWOOLMember 2026-09-30 0001756180 NCRA:QMAXVIEAgreementsMember 2026-07-26 2026-07-29 0001756180 NCRA:QMAXVIEAgreementsMember 2026-07-29 0001756180 NCRA:QMAXVIEAgreementsMember 2026-07-01 2026-09-30 0001756180 NCRA:QMAXVIEAgreementsMember 2026-01-01 2026-09-30 0001756180 NCRA:AccruedExpensesMember 2026-09-30 0001756180 NCRA:AccruedExpensesMember 2025-12-31 0001756180 NCRA:OtherLiabilities1Member 2026-09-30 0001756180 NCRA:OtherLiabilities1Member 2025-12-31 0001756180 NCRA:SecuritiesPurchaseAgreementMember NCRA:SeniorSecuredConvertibleNoteMember 2025-10-31 0001756180 NCRA:SecuritiesPurchaseAgreementMember NCRA:SeniorSecuredConvertibleNoteMember 2025-11-03 0001756180 NCRA:SecuritiesPurchaseAgreementMember NCRA:SeniorSecuredConvertibleNoteMember 2025-11-02 2025-11-03 0001756180 2025-01-01 2025-12-31 0001756180 NCRA:InitialNoteMember 2025-12-01 2025-12-31 0001756180 NCRA:InitialNoteMember 2026-07-01 2026-09-30 0001756180 NCRA:AlternateConversionFloorAmountsMember 2026-07-29 0001756180 NCRA:AlternateConversionFloorAmountsMember 2026-07-26 2026-07-29 0001756180 NCRA:AlternateConversionFloorAmountsMember 2026-09-30 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputExercisePriceMember 2026-01-01 2026-09-30 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputExercisePriceMember 2025-01-01 2025-12-31 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-09-30 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-01-01 2025-12-31 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-01-01 2026-09-30 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-01-01 2025-12-31 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-09-30 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputExpectedTermMember 2025-01-01 2025-12-31 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-09-30 0001756180 NCRA:IPOWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2025-01-01 2025-12-31 0001756180 us-gaap:WarrantMember 2025-12-31 0001756180 us-gaap:WarrantMember 2024-12-31 0001756180 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001756180 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001756180 us-gaap:WarrantMember 2026-09-30 0001756180 NCRA:IPOWarrantMember 2026-09-30 0001756180 us-gaap:WarrantMember NCRA:IPOWarrantMember 2025-12-31 0001756180 us-gaap:WarrantMember NCRA:IPOWarrantMember 2025-01-01 2025-12-31 0001756180 us-gaap:WarrantMember NCRA:IPOWarrantMember 2026-01-01 2026-09-30 0001756180 us-gaap:WarrantMember NCRA:IPOWarrantMember 2026-09-30 0001756180 2026-06-24 2026-06-25 0001756180 NCRA:EquityPurchaseFacilityAgreementMember 2026-05-21 2026-05-22 0001756180 NCRA:EquityPurchaseFacilityAgreementMember 2026-05-22 0001756180 NCRA:EquityPurchaseFacilityAgreementMember 2026-05-21 2026-05-22 0001756180 NCRA:EquityPurchaseFacilityAgreementMember 2026-05-22 0001756180 NCRA:EquityPurchaseFacilityAgreementMember 2026-07-07 2026-07-08 0001756180 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001756180 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001756180 us-gaap:SeriesBPreferredStockMember 2026-04-01 2026-06-30 0001756180 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001756180 NCRA:StockOptionAward2018IncentivePlanMember 2026-04-15 0001756180 NCRA:ConvertibleNoteHolderMember 2026-07-07 2026-07-09 0001756180 NCRA:QMAXVIEAgreementsMember 2026-07-28 0001756180 NCRA:QMAXVIEAgreementsMember 2026-07-27 2026-07-28 0001756180 NCRA:AndyJinMember 2026-07-29 0001756180 NCRA:SongYuanTengMember 2026-07-29 0001756180 NCRA:ChienHuaTsengMember 2026-08-17 0001756180 NCRA:ShunChihChuangMember 2026-08-17 0001756180 NCRA:StockOptionAward2018IncentivePlanMember 2026-08-20 0001756180 NCRA:PhoenixMGMTAndConsultingLLCMember 2026-09-03 0001756180 us-gaap:SeriesAPreferredStockMember 2021-08-31 0001756180 us-gaap:SeriesBPreferredStockMember 2025-08-28 0001756180 us-gaap:SeriesBPreferredStockMember 2025-08-27 2025-08-29 0001756180 us-gaap:SeriesBPreferredStockMember 2025-08-29 0001756180 us-gaap:CommonStockMember NCRA:SeriesBPreferredIntoCommonStockMember NCRA:PreStockSplitMember 2026-07-01 2026-09-30 0001756180 us-gaap:CommonStockMember NCRA:SeriesBPreferredIntoCommonStockMember NCRA:PostStockSplitMember 2026-07-01 2026-09-30 0001756180 us-gaap:SeriesBPreferredStockMember NCRA:SeriesBPreferredIntoCommonStockMember NCRA:PreStockSplitMember 2026-07-01 2026-09-30 0001756180 NCRA:Plan2018Member 2026-09-30 0001756180 srt:ChiefFinancialOfficerMember NCRA:ShunChihChuangMember 2026-08-16 2026-08-17 0001756180 NCRA:ShunChihChuangMember 2026-07-01 2026-09-30 0001756180 NCRA:ShunChihChuangMember 2026-01-01 2026-09-30 0001756180 NCRA:TsengMember 2026-08-16 2026-08-17 0001756180 NCRA:PRCMember 2026-01-01 2026-09-30 0001756180 country:TW 2026-01-01 2026-09-30 0001756180 us-gaap:ForeignCountryMember 2026-01-01 2026-09-30 0001756180 us-gaap:ForeignCountryMember 2025-01-01 2025-09-30 0001756180 NCRA:MountainShareTransferLLCMember 2026-09-30 0001756180 NCRA:MountainShareTransferLLCMember 2025-12-31 0001756180 NCRA:EstateOfYinChiehChengMember 2026-09-30 0001756180 NCRA:EstateOfYinChiehChengMember 2025-12-31 0001756180 2026-07-02 0001756180 2026-01-02 0001756180 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-09-30 0001756180 us-gaap:SeriesAPreferredStockMember 2025-01-01 2025-09-30 0001756180 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-09-30 0001756180 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-09-30 0001756180 us-gaap:ConvertibleDebtMember 2026-01-01 2026-09-30 0001756180 us-gaap:ConvertibleDebtMember 2025-01-01 2025-09-30 0001756180 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001756180 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001756180 NCRA:ContingentlyIssuableCommonSharesMember 2026-01-01 2026-09-30 0001756180 NCRA:ContingentlyIssuableCommonSharesMember 2025-01-01 2025-09-30 0001756180 us-gaap:SeriesAPreferredStockMember 2026-07-01 2026-09-30 0001756180 us-gaap:SeriesAPreferredStockMember 2025-07-01 2025-09-30 0001756180 us-gaap:SeriesBPreferredStockMember 2026-07-01 2026-09-30 0001756180 NCRA:StrategicAdvisoryAgreementMember 2026-05-18 0001756180 us-gaap:RestrictedStockMember NCRA:StrategicAdvisoryAgreementMember 2026-05-18 0001756180 NCRA:StrategicAdvisoryAgreementMember 2026-05-17 2026-05-18 0001756180 NCRA:StrategicAdvisoryAgreementMember 2026-09-30 0001756180 NCRA:StrategicAdvisoryAgreementMember us-gaap:CommonStockMember 2026-05-17 2026-05-18 0001756180 NCRA:CateringMember 2025-07-01 2025-09-30 0001756180 NCRA:CateringMember 2025-01-01 2025-09-30 0001756180 NCRA:FishTradingMember 2026-07-01 2026-09-30 0001756180 NCRA:ECommerceMember 2026-07-01 2026-09-30 0001756180 NCRA:ElectronicComponentsTradingMember 2026-07-01 2026-09-30 0001756180 us-gaap:OperatingSegmentsMember 2026-07-01 2026-09-30 0001756180 NCRA:FishTradingMember 2025-07-01 2025-09-30 0001756180 NCRA:ECommerceMember 2025-07-01 2025-09-30 0001756180 us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0001756180 NCRA:FishTradingMember 2026-01-01 2026-09-30 0001756180 NCRA:ECommerceMember 2026-01-01 2026-09-30 0001756180 NCRA:ElectronicComponentsTradingMember 2026-01-01 2026-09-30 0001756180 us-gaap:OperatingSegmentsMember 2026-01-01 2026-09-30 0001756180 NCRA:FishTradingMember 2025-01-01 2025-09-30 0001756180 NCRA:ECommerceMember 2025-01-01 2025-09-30 0001756180 us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0001756180 us-gaap:SalesRevenueSegmentMember country:TW 2026-01-01 2026-09-30 0001756180 us-gaap:SalesRevenueSegmentMember country:JP 2026-01-01 2026-09-30 0001756180 us-gaap:SalesRevenueSegmentMember NCRA:OtherForeignCountriesMember 2026-01-01 2026-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure NCRA:Integer

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED September 30, 2026

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM _______ TO _______

 

COMMISSION FILE NO.: 001-41434

 

NOCERA, INC.

(Exact name of registrant as specified in charter)

 

Nevada   16-1626611
(State or other jurisdiction of incorporation)   (IRS Employer Identification No.)

 

3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City Taiwan 221, ROC

(Address of principal executive offices and zip code)

 

(886)-910-163-358

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share NCRA Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

As of November 16, 2026, the registrant had 2,601,612 shares of common stock issued and outstanding.

 

 

 

   

 

 

TABLE OF CONTENTS

 

 

Cautionary Statement Regarding Forward-Looking Statements ii
     
PART I FINANCIAL INFORMATION 1
     
ITEM 1. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 1
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 26
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 32
ITEM 4. CONTROLS AND PROCEDURES 32
     
PART II OTHER INFORMATION 34
     
ITEM 1. LEGAL PROCEEDINGS 34
ITEM 1A. RISK FACTORS 34
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 35
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 35
ITEM 4 MINE SAFETY DISCLOSURES 35
ITEM 5 OTHER INFORMATION 35
ITEM 6 EXHIBITS 36
     
SIGNATURES 37

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 i 

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “anticipate,” “predict,” “project,” “forecast,” “potential,” and “continue” or the negatives thereof or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees of future performance. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied by such forward-looking statements.

 

We cannot predict all the risks and uncertainties that may impact our business, financial condition or results of operations. Accordingly, the forward-looking statements in this Quarterly Report on Form 10-Q should not be regarded as representations that the results or conditions described in such statements will occur or that our objectives and plans will be achieved. These forward-looking statements are found at various places throughout this Quarterly Report on Form 10-Q and include information concerning possible or projected future results of our operations, including statements about potential acquisition or merger targets, strategies or plans; business strategies; prospects; future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results; and any other statements that are not historical facts.

 

These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to a variety of factors and risks, including, but not limited to, those set forth under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) on April 15, 2026, as amended on August 28, 2026.

 

Many of those risk factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. Considering these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. All subsequent written and oral forward-looking statements concerning other matters addressed in this Quarterly Report on Form 10-Q and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Quarterly Report on Form 10-Q.

 

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

 

 

 

 

 

 

 ii 

 

 

PART I FINANCIAL INFORMATION

 

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars except for Number of Shares)

         
  

September 30,

2026

  

December 31,

2025

 
   (Unaudited)   (As Restated) 
   $   $ 
ASSETS          
Current assets          
Cash and cash equivalents   1,020,689    7,952,180 
Accounts receivable   –    – 
Advance to suppliers   799,667    – 
Prepaid expenses and other current assets   362,916    317,162 
Financial assets at fair value through profit or loss   –    – 
Other current asset   4,655,189    – 
Total current assets   6,838,461    8,269,342 
Equity method investments   1,213,471    924,152 
Property and equipment, net   2,330    882,783 
Right-of-use assets   28,003    34,942 
Total assets   8,082,265    10,111,219 
LIABILITIES AND EQUITY          
Liabilities          
Current liabilities          
Income tax payable   301,143    336,936 
Accrued expenses and other liabilities   121,808    121,961 
Dividend payable   70,312    177,326 
Due to related parties   25,467    23,565 
Financial lease liabilities - current   8,039    7,398 
Warrant liability   –    25,859 
Total current liabilities   526,769    693,045 
Financial Liability at FVTPL   24,347    7,205,666 
Lease liability   12,935    18,243 
Total liabilities   564,051    7,916,954 
Commitments and contingencies (Note 17)   –    – 
Mezzanine Equity          
9.00% Convertible preferred stock ($0.001 par value; Series B Preferred Stock, 1,000,000 shares authorized. 0 and 3,500 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively)   –    2,635,000 
Total mezzanine equity   –    2,635,000 
Equity          
Common stock ($0.001 par value; authorized 200,000,000 shares; 2,396,612 shares and 481,121 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively, as adjusted for the 1-for-30 reverse stock split effected on July 6, 2026; see Note 11)   2,397    481 
Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 shares authorized, 80,000 shares issued and outstanding as of September 30, 2026 and December 31, 2025)   80    80 
Additional paid-in capital   37,368,550    25,465,037 
Statutory and other reserves   191,219    191,219 
Accumulated losses   (30,163,566)   (26,188,471)
Accumulated other comprehensive income   119,534    90,919 
Total Nocera, Inc.’s stockholders’ equity   7,518,214    (440,735)
Non-controlling interests   –    – 
Total equity   7,518,214    (440,735)
Total liabilities, mezzanine equity, and equity   8,082,265    10,111,219 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements.

 

 1 

 

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Stated in US Dollars except for Number of Shares)

                 
   Three months ended
September 30,
   Nine months ended
September 30,
 
   2026   2025   2026   2025 
   (Unaudited)   (As Restated)   (Unaudited)   (As Restated) 
   $   $   $   $ 
Net sales   2,155,280    1,509,971    6,572,628    7,529,938 
Cost of sales   (1,700,418)   (1,465,514)   (6,057,788)   (7,408,111)
Gross profit   454,862    44,457    514,840    121,827 
                     
Operating expenses                    
General and administrative expenses   (1,346,402)   (808,378)   (2,557,093)   (1,269,029)
Share based compensation   (181,996)   –    (783,086)   – 
Total operating expenses   (1,528,398)   (808,378)   (3,340,179)   (1,269,029)
                     
Loss from operations   (1,073,536)   (763,921)   (2,825,339)   (1,147,202)
                     
Other expense   (86,510)   (688,687)   (1,149,756)   (646,468)
Net loss before income taxes   (1,160,046)   (1,452,608)   (3,975,095)   (1,793,670)
Income tax expense   –    (2,870)   –    (143,431)
Net loss from continuing operations   (1,160,046)   (1,455,478)   (3,975,095)   (1,937,101)
                     
Net loss from discontinued operations   –    (56,172)        (158,860)
Net loss   (1,160,046)   (1,511,650)   (3,975,095)   (2,095,961)
Less: Preferred dividend   –    –    (70,126)     
Less: Net loss attributable to non-controlling interests   –    (11,235)   –    (31,772)
Net loss attributable to common stockholders   (1,160,046)   (1,500,415)   (4,045,221)   (2,064,189)
                     
Comprehensive loss                    
Net loss   (1,160,046)   (1,511,650)   (3,975,095)   (2,095,961)
Foreign currency translation gain   24,675    1,111    28,615    46,983 
Total comprehensive loss   (1,135,371)   (1,510,539)   (3,946,480)   (2,048,978)
                     
Less: comprehensive loss attributable to non-controlling interest   –    (11,235)   –    (31,772)
Less: Foreign currency translation (loss) gain attributable to noncontrolling interest   –    (719)   –    2,301 
Comprehensive loss attributable to the Company   (1,135,371)   (1,498,585)   (3,946,480)   (2,019,507)
                     
Loss per share – basic and diluted   (0.4840)   (3.1329)   (1.6879)   (4.3101)
Net loss per share from continuing operations – basic and diluted   (0.4840)   (3.0156)   (1.6879)   (3.9784)
Net loss per share from discontinued operations – basic and diluted   –    (0.1173)   –    (0.3317)
                     
Weighted average number of common shares outstanding – basic and diluted *   2,396,612    478,918    2,396,612    478,918 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements.

 

* Weighted average shares outstanding and net loss per share for all periods presented have been retroactively adjusted to reflect the 1-for-30 reverse stock split effected on July 6, 2026. See Note 11.

 

 2 

 

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars except for Number of Shares)

         
   Nine months ended September 30, 
   2026   2025 
   (Unaudited)   (As Restated) 
   $   $ 
Cash flows from operating activities:          
Net loss   (3,975,095)   (2,095,961)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation expenses   10,973    210,186 
Amortization   –    12,228 
Unrealized losses on digital assets   481,301    – 
Loss on disposal of property, plant and equipment   223,266      
Share of loss of equity method investments   118,681    315,224 
Loss on disposal of SY Media   –    (87,603)
Gain on fair value change of financial assets held for trading   –    (3)
Non-cash interest expenses arisen from convertible note   330,806    – 
Non-cash interest expenses on lease liability   138    419 
Share-based compensation expense   1,243,290    – 
Changes in operating assets and liabilities:          
Accounts receivable, net   –    17,890 
Advance to suppliers   (797,935)     
Prepaid expenses and other assets, net   (47,234)   125,413 
Other non-current assets   –    1,015 
Other payables and accrued liabilities   2,317    (172,820)
Income tax payable   (35,793)   109,598 
Warrant liability   (25,859)     
Subtract non-cash gain on warrant liabilities   (132)   451,312 
Net cash used in operating activities   (2,471,276)   (1,113,102)
           
Cash flows from investing activities:          
Proceeds from sale of property and equipment   654,604    – 
Proceeds from disposal of financial assets at FVTPL   –    213 
Proceeds from disposal of digital assets   1,518,699      
Disposal of subsidiary   –    363,845 
Acquisition of associate   –    (500,000)
Purchases of digital assets   (2,000,000)   – 
Increase in refundable deposits   (4,655,189)     
Net cash used in investing activities   (4,481,886)   (135,942)
           
Cash flows from financing activities:          
Proceeds from issuance of common stock   –    240,000 
Proceeds from issuance of preferred stock, net        2,635,000 
Proceeds from secured other borrowing   –    (286)
Payment of lease liabilities   (5,767)   (3,890)
Net cash (used in) provided by financing activities   (5,767)   2,870,824 
           
Net effect of exchange rate changes on cash and cash equivalents   27,438    (71,736)
Net decrease in cash and cash equivalents   (6,931,491)   1,550,044 
Cash and cash equivalents at beginning of period   7,952,180    484,161 
Cash and cash equivalents at end of period   1,020,689    2,034,205 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements.

 

 

 3 

 

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Stated in US Dollars except Number of Shares)

(UNAUDITED)

                                                     
   Mezzanine Equity   Shareholders’ Equity             
   Convertible
Preferred Stock
   Common Stock*   Preferred Stock   Additional
Paid-in
   Statutory
and
other
   Accumulated   Accumulated
Other
Comprehensive
   Total
Nocera Inc.’s
Stockholders’
   Non-
controlling
   Total
Stockholders’
 
   Stock   Amount   Stock   Amount   Stock   Amount   Capital   Reserves   Losses   Income   Equity   Interests   Equity 
       $       $       $   $   $   $   $   $   $   $ 
Balance, January 1, 2025  –   –   468,251   468   80,000   80   25,213,844   191,219   (23,335,453)  24,018   2,094,176   40,434   2,134,610 
Common stock issuance  –   –   10,667   11   –   –   2,874,985   –   –   –   2,875,000   –   2,875,000 
Foreign currency translation adjustments  –   –   –   –   –   –   –   –   –   44,682   44,682   2,301   46,983 
Convertible preferred stock issuance  3,500   3,500,000   –   –   –   –   –   –   –   –   –   –   – 
Net loss  –   –   –   –   –   –   –   –   (2,064,189)  –   (2,064,189)  (31,772)  (2,095,961)
Balance, September 30, 2025  3,500   3,500,000   478,918   479   80,000   80   28,088,829   191,219   (25,399,642)  68,700   2,949,669   10,963   2,960,632 
                                                     
                                                     
Balance, January 1, 2026  3,500   2,635,000   481,121   481   80,000   80   25,465,037   191,219   (26,188,471)  90,919   (440,735)  –   (440,735)
Common stock issuance  –   –   28,883   29   –   –   354,218   –   –   –   354,247   –   354,247 
Convertible preferred stock converted into common stock  (340)  (340,000)  –   –   –   –   –   –   –   –   –   –   – 
Foreign currency translation adjustments  –   –   –   –   –   –   –   –   –   1,379   1,379   –   1,379 
Preferred stock dividend  –   –   –   –   –   –   (70,126)  –   –   –   (70,126)  –   (70,126)
Net loss  –   –   –   –   –   –   –   –   (1,273,741)  –   (1,273,741)  –   (1,273,741)
Balance, March 31, 2026  3,160   2,295,000   510,004   510   80,000   80   25,749,129   191,219   (27,462,212)  92,298   (1,428,976)  –   (1,428,976)
Convertible preferred stock converted into common stock  (3,160)  (2,295,000)  374,080   374   –   –   2,457,519   –   –   –   2,457,893   –   2,457,893 
Common stock issuance  –   –   676,126   676   –   –   5,944,184   –   –   –   5,944,860   –   5,944,860 
Foreign currency translation adjustments  –   –   –   –   –   –   –   –   –   2,561   2,561   –   2,561 
Preferred stock dividend  –   –   –   –   –   –   –   –   –   –   –   –   – 
Net loss  –   –   –   –   –   –   –   –   (1,541,308)  –   (1,541,308)  –   (1,541,308)
Balance, June 30, 2026  –   –   1,560,210   1,560   80,000   80   34,150,832   191,219   (29,003,520)  94,859   5,435,030   –   5,435,030 
Convertible preferred stock issuance  –   –   –   –   –   –   –   –   –   –   –   –   – 
Common stock issuance  –   –   836,402   837   –   –   3,217,718   –   –   –   3,218,555   –   3,218,555 
Foreign currency translation adjustments  –   –   –   –   –   –   –   –   –   24,675   24,675   –   24,675 
Preferred stock dividend  –   –   –   –   –   –   –   –   –   –   –   –   – 
Net loss  –   –   –   –   –   –   –   –   (1,160,046)  –   (1,160,046)  –   (1,160,046)
Balance, September 30, 2026  –   –   2,396,612   2,397   80,000   80   37,368,550   191,219   (30,163,566)  119,534   7,518,214   –   7,518,214 

 

 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements.

 

* Common stock presented in this statement for all periods have been retroactively adjusted to reflect the 1-for-30 reverse stock split effected on July 6, 2026. See Note 11.

 

 4 

 

 

NOCERA, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

Note 1      DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

 

Business Description

 

Nocera is a Nevada corporation headquartered in New Taipei City, Taiwan. As of the date of this Quarterly Report on Form 10-Q, our business operations consist primarily of three segments: (i) Fish Trading, (ii) E-Commerce, and (iii) Electronic Components Trading. Our Fish Trading segment is carried out by the Company’s Taiwan branch, Nocera Inc. Taiwan Branch (“NTB”). NTB engages in the trading of fish, primarily eels, in Taiwan. In the E-Commerce segment, which is administered through Zhejiang Xinca Mutual Entertainment Culture Media Co., Ltd. (“Xinca”), a variable interest entity located in the People’s Republic of China (“PRC”) that the Company consolidates as its primary beneficiary (see Note 2), we act as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. In addition, we design recirculation aquaculture systems (“RAS”) for fish farming, and we consult with customers in the manufacture and installation of RAS.

 

The Company is transitioning toward a diversified, technology-focused holding company, with an emphasis on opportunities across artificial intelligence (“AI”), AI infrastructure, data centers, edge computing, energy, and energy storage. The Company has also commenced its business activities to include electronic components, initially focusing on memory products. The Company intends to expand its trading operations to include additional electronic components and semiconductor-related products as market opportunities develop.

 

Going concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared on a going-concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited condensed consolidated financial statements, for the three months and nine months ended September 30, 2026, the Company recorded a net loss of $1,160,046 and $3,975,095, respectively, and net cash used in operating activities of $1,392,363 and $2,471,276, respectively. As of September 30, 2026, the Company had an accumulated deficit of $30,163,566, compared to $26,188,471 as of December 31, 2025. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

In July 2026, the Company received a notice of default under its senior secured convertible note, following which the collateral agent applied approximately $4.7 million from the Company’s blocked custodial account against amounts claimed under the note (see Note 9). The Company is in discussions with the noteholder regarding the remaining amounts claimed, including a potential waiver.

 

Management’s plans to address these conditions include, but are not limited to, (i) seeking additional capital through equity financing arrangements with existing shareholders and potential new investors, (ii) pursuing strategic financing alternatives, including debt financing, to improve liquidity, (iii) implementing cost control measures to reduce operating expenses, and (iv) expanding revenue-generating activities through the development of new business opportunities and enhancement of existing operations.

 

The Company is currently in discussions with potential investors and financing sources; however, other than the Equity Purchase Facility Agreement described in Note 11, no definitive agreements have been executed as of the date of issuance of these financial statements. Accordingly, there can be no assurance that the Company will be successful in obtaining sufficient funding or achieving its business objectives.

 

Even if the Company is able to obtain additional financing, such financing may not be available on favorable terms, and may include restrictive covenants in the case of debt financing or result in significant dilution to existing stockholders in the case of equity financing. Therefore, management has concluded that substantial doubt about the Company’s ability to continue as a going concern has not been alleviated.

 

 

 

 5 

 

 

Basis of Presentation

 

The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on April 15, 2026, as amended on August 28, 2026.

 

The unaudited condensed consolidated financial statements and the accompanying notes have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented. The consolidated results of operations for any interim period are not necessarily indicative of the results to be expected for the full year or for any other future years or interim periods.

 

On July 6, 2026, the Company effected a 1-for-30 reverse stock split of its common stock (the “Reverse Stock Split”). All share and per-share amounts included in these unaudited condensed consolidated financial statements and accompanying notes, including common stock issued and outstanding, weighted average shares outstanding, net loss per share, warrants, and shares reserved for issuance, have been retroactively adjusted to reflect the Reverse Stock Split for all periods presented, unless otherwise indicated. For periods prior to the Reverse Stock Split, share and per-share amounts have been retroactively restated by dividing the historical amounts by 30, the ratio of the Reverse Stock Split, and rounding to the nearest whole share; such restatement did not involve the actual issuance, cancellation, or cash settlement of any shares, which occurred only in connection with the Reverse Stock Split effected on July 6, 2026. See Note 11.

 

Restatement of Previously Issued Financial Statements

 

On August 14, 2026, the Board of Directors of the Company, after discussion with management and in consultation with the Company’s independent registered public accounting firm, concluded that the Company’s previously issued consolidated financial statements for the fiscal years ended December 31, 2024 and December 31, 2025, as included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed April 15, 2026, as amended on April 21, 2026, and the Company’s unaudited interim condensed consolidated financial statements for the quarterly periods ended March 31, 2025, June 30, 2025, and September 30, 2025, should no longer be relied upon due to errors identified in those financial statements. The Company filed Amendment No. 2 to its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025 on August 28, 2026.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform with current year presentation.

 

Concentrations of Credit Risk

 

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.

 

 

 

 6 

 

 

The following table summarizes the significant customers’ revenue as a percentage of total revenue:

                
   Three months ended
September 30,
   Nine months ended
September 30,
 
   2026   2025   2026   2025 
Revenue                    
Customer A   –    14.58%    –    81.96% 
Customer B   –    40.37%    10.45%    – 
Customer C   –    –    –    – 
Customer D   –    34.28%    –    13.14% 
Customer E   –    –    10.07%    – 
Customer F   –    –    12.60%    – 
Customer G   –    –    13.03%    – 
Customer H   –    –    12.59%    – 
Customer I   72.13%    –    –    – 
    72.13%    89.23%    58.74%    95.10% 

 

The Company does not have accounts receivable outstanding as of September 30, 2026 and December 31, 2025.

 

Recent Accounting Pronouncements

 

The Company has evaluated recently issued accounting pronouncements, including ASU 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60), ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, and ASU 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The Company is evaluating the impact of these pronouncements on its condensed consolidated financial statements and related disclosures. Other recently issued pronouncements are not expected to have a material impact on the condensed consolidated financial statements.

 

Fair Value Measurement

 

The Company follows Accounting Standards Codification (“ASC”) 820, Fair Value Measurement (“ASC 820”), which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for inputs used in measuring fair value:

 

  · Level 1: Quoted prices in active markets for identical assets or liabilities.
  · Level 2: Observable inputs other than Level 1, either directly or indirectly.
  · Level 3: Unobservable inputs, used when observable inputs are not available.

 

The Company measures certain financial instruments at fair value on a recurring basis, including warrant liabilities and convertible notes. When observable market data is available, such inputs are used to measure fair value. When observable inputs are not available, the Company applies valuation techniques which require management to develop significant estimates and assumptions.

 

Certain non-financial assets, including goodwill, intangible assets and long-lived assets, are measured at fair value on a non-recurring basis when indicators of impairment exist.

 

 

 

 7 

 

 

Note 2      VARIABLE INTEREST ENTITY (“VIE”)

 

The Company consolidates Xinca, a VIE for which the Company is determined to be the primary beneficiary in accordance with ASC 810, Consolidation, as disclosed in Note 2 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on April 15, 2026.

 

The Company does not have any equity ownership interest in its consolidated VIEs. The Company’s involvement with these VIEs is through contractual arrangements that provide the Company with (i) the power to direct the activities that most significantly impact the VIEs’ economic performance and (ii) the right to receive substantially all of the economic benefits of the VIEs, while also obligating the Company to absorb losses that could potentially be significant.

 

The assets of the consolidated VIEs may only be used to settle the obligations of the respective VIEs and are not available to satisfy the obligations of the Company, except as otherwise permitted under the relevant contractual arrangements. The creditors of the consolidated VIEs do not have recourse to the general credit of the Company.

 

The following tables present the carrying amounts of the assets and liabilities of the Company’s consolidated VIEs included in the unaudited condensed consolidated balance sheets as of September 30, 2026 and December 31, 2025.

          
   September 30,
2026
   December 31,
2025
 
   (Unaudited)   (Audited) 
   $   $ 
Cash and bank balance   166,048    112,551 
Prepaid expense and other receivables   7,452    39,430 
Property and equipment, net   10,725    47,216 
Accrued expense and other liabilities   (1,866)   (78,875)
Long-term secured other borrowing   (20,974)   (31,296)
Net assets value   161,385    89,026 

 

QMAX Technology Co., Ltd. (“QMAX”) is a VIE in which the Company holds a variable interest as described in Note 7. The Company has determined that it is not the primary beneficiary of QMAX and therefore does not consolidate QMAX. The Company’s maximum exposure to loss as a result of its involvement with QMAX is limited to the carrying amount of its equity method investment, which was $410,906 as of September 30, 2026.

 

Note 3      ACCOUNTS RECEIVABLE

 

The Company assesses the collectability of its receivables on a quarterly basis. For the nine months ended September 30, 2026 and 2025, the Company recorded no provision for credit losses.

 

 

 

 8 

 

 

Note 4     PREPAID EXPENSES AND OTHER CURRENT ASSETS

        
   September 30,
2026
   December 31,
2025
 
   (Unaudited)   (As Restated) 
   $   $ 
Prepaid expenses   51,487    315,430 
Other assets   311,429    1,732 
Total   362,916    317,162 

 

Other assets as of September 30, 2026 include other receivables of $107,126, representing reimbursements due from customers. Advances to suppliers, representing prepayments for raw materials, are presented separately on the condensed consolidated balance sheets and were $799,667 and $0 as of September 30, 2026 and December 31, 2025, respectively.

 

Note 5      PROPERTY AND EQUIPMENT, NET 

 

As of September 30, 2026 and December 31, 2025, property and equipment consisted of the following:

          
   September 30,
2026
   December 31,
2025
 
   (Unaudited)   (As Restated) 
   $   $ 
Land   –    877,870 
Equipment   12,439    11,940 
Less: Accumulated depreciation   (10,109)   (7,027)
Property and equipment, net   2,330    882,783 

 

On August 7, 2026, the Company completed the sale of the land located in Alabama, which was carried at a book value of $877,870, to individuals who are not affiliated with the Company for an aggregate consideration of $700,000 in cash. As a result of the disposition, the Company recognized a loss on sale of $178,000. After deducting seller settlement charges, the Company received net cash proceeds of approximately $654,604. The land was sold in “as is” condition, without representation or warranty, express or implied, as to its condition.

 

Depreciation expenses for the three months ended September 30, 2026 and 2025 were $3,712 and $10,842, respectively. Depreciation expenses for the nine months ended September 30, 2026 and 2025 were $10,973 and $210,186, respectively.

 

Note 6     RIGHT-OF-USE ASSETS

 

The Company adopted ASU (“Accounting Standards Update”) No. 2016-02 Leases, on January 1, 2019, the beginning of fiscal year 2019, using the modified retrospective approach. The Company determines whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if we obtain the rights to direct the use of and to obtain substantially all of the economic benefit from the use of the underlying asset. Some of our leases include both lease and non-lease components which are accounted for as a single lease component as the Company has elected the practical expedient. Some of the operating lease agreements include variable lease costs, primarily taxes, insurance, common area maintenance or increases in rental costs related to inflation. Substantially all of our equipment leases and some of our real estate leases have terms of less than one year and, as such, are accounted for as short-term leases as we have elected the practical expedient.

 

 

 

 9 

 

 

Operating leases are included in the right-of-use lease assets, current lease liabilities and long-term lease liabilities on the Consolidated Balance Sheet. Right-of-use assets and lease liabilities are recognized at each lease’s commencement date based on the present values of its lease payments over its respective lease term. When a borrowing rate is not explicitly available for a lease, the incremental borrowing rate is used based on information available at the lease’s commencement date to determine the present value of its lease payments. Operating lease payments are recognized on a straight-line basis over the lease term

 

The carrying amount of right-of-use assets by class of underlying asset are as follows:

          
   September 30,
2026
  December 31,
2025
    $     $  
At cost:          
Equipment   47,605    43,453 
Less: Accumulated depreciation   (19,602)   (8,511)
Right-of-use assets, net   28,003    34,942 

 
The table below presents the lease-related assets and liabilities recorded on the balance sheet.

          
   September 30,
2026
  December 31,
2025
    $     $  
Assets          
Finance lease, right-of-use asset, net   28,003    34,942 
Right-of-use assets, net   28,003    34,942 
           
Liabilities          
Current          
Finance lease liability   8,039    7,398 
           
Non-current          
Finance lease liability   12,935    18,243 
           
Total Finance lease liabilities   20,974    25,641 

  

Components of Lease Expense

 

We recognize lease expense on a straight-line basis over the term of the operating leases, as reported within “general and administrative” expense on the accompanying consolidated statement of operations.

 

 

 

 10 

 

 

Note 7     EQUITY INVESTMENTS

 

Tachyonext Inc. (“Tachyonext”)

 

On June 5, 2025, the Company acquired a 35% equity interest in Tachyonext, a US-based e-commerce company, for total cash consideration of $500,000. The Company has significant influence over Tachyonext through its ownership interest and participation in certain strategic and operating decisions, and accordingly accounts for this investment using the equity method.

 

For the three months and nine months ended September 30, 2026, the Company recognized income of $18,130 and a loss of $121,587, respectively, representing its proportionate share of Tachyonext’s results. As of September 30, 2026 and December 31, 2025, the carrying value of the investment in Tachyonext was $402,565 and $524,152, respectively. The Company evaluated this investment for impairment as of December 31, 2025 and determined that no impairment indicators were present.

 

LONGWOOL (“Longwool”)

 

On December 1, 2025, the Company entered into a stock purchase agreement with Longwool, a French corporation, to acquire an equity interest representing 35% of Longwool’s outstanding equity for total cash consideration of $400,000. The transaction closed on January 1, 2026. The cash consideration paid in December 2025 was recorded as a prepaid investment as of December 31, 2025. The Company began accounting for this investment using the equity method in January 2026, as the Company obtained significant influence over Longwool at that time.

 

For the three months and nine months ended September 30, 2026, the Company recognized a loss of $0 and $0, respectively, representing its proportionate share of Longwool’s net gain. As of September 30, 2026, the carrying value of the investment in Longwool was $400,000.

 

QMAX Technology Co., Ltd. (“QMAX”)

 

On July 28, 2026, the Company entered into a series of agreements (collectively, the “QMAX VIE Agreements”) with QMAX, a company registered in Taiwan that provides memory and storage solutions, and with the holder of 30% of QMAX’s equity (the “Seller”). The QMAX VIE Agreements consist of a voting proxy, an equity pledge, an exclusive call option and an exclusive business cooperation agreement, each with a ten-year term and terminable only by the Company. Pursuant to the QMAX VIE Agreements, the Company obtained voting rights and economic rights with respect to the Seller’s 30% equity interest in QMAX. The consideration transferred consisted of 300,000 shares of the Company’s common stock with an aggregate fair value of $408,000. The Seller remains the registered legal owner of the equity interest, and no transfer of registered legal title was effected. The Company has determined that QMAX is a variable interest entity and that the Company is not its primary beneficiary. Through its rights with respect to the Seller’s 30% equity interest, the Company has the ability to exercise significant influence, but not control, over QMAX’s operating and financial policies, and accounts for its investment under the equity method. For the three months and nine months ended September 30, 2026, the Company recognized a gain of $2,906, representing its proportionate share of QMAX’s net income. As of September 30, 2026, the carrying value of the investment in QMAX was $410,906.

 

Note 8     ACCRUED EXPENSES AND OTHER LIABILITIES

 

As of September 30, 2026 and December 31, 2025, accrued expenses and other liabilities consisted of the following:

          
   September 30,
2026
  December 31,
2025
    $     $  
Accrued expenses   28,789    28,833 
Other liabilities   93,019    93,128 
Accrued expenses and other liabilities   121,808    121,961 

  

 

 

 11 

 

 

Note 9      CONVERTIBLE NOTE

 

On October 31, 2025, the Company entered into a Securities Purchase Agreement (the “Original SPA”) with an institutional accredited investor (the “SPA Buyer”), pursuant to which the Company may issue and sell, in multiple closings, senior secured convertible notes in an aggregate original principal amount of up to $300,000,000. At the initial closing on November 3, 2025, the Company issued a senior secured convertible note in the principal amount of $8,000,000 (the “Note”) for a purchase price of $7,280,000, reflecting an original issue discount of $720,000. The Note bears interest at 9.0% per annum, payable monthly in arrears, and matures on November 3, 2027. Upon the occurrence of an event of default, as defined in the Note, the interest rate increases to 18.0% per annum.

 

The Note is secured by a first-priority security interest in substantially all of the Company’s assets purchased or acquired with the proceeds from the sale of the Note, pursuant to a Pledge and Security Agreement and an Account Control Agreement, each dated as of November 3, 2025. The Note ranks senior to all existing and future indebtedness of the Company, subject to certain permitted indebtedness exceptions.

 

The Note is convertible at any time at the option of the holder into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The conversion price is equal to the lower of: (A) The lower of (i) $2.01, and (ii) the average closing price of the Common Stock for the five trading days immediately preceding the closing; and (B) 93% of the lowest daily volume-weighted average price (“VWAP”) of the Common Stock during the ten trading days immediately preceding the conversion date.

 

The conversion price is subject to a floor price and customary adjustments. The holder is restricted from converting the Note if such conversion would result in the holder beneficially owning more than 4.99% of the outstanding Common Stock, which may be increased to 9.99% upon 61 days’ prior written notice.

 

The Company elected the fair value option for the Note in accordance with ASC 825, Financial Instruments. Accordingly, the Note is measured at fair value at each reporting date, with changes in fair value recorded in other expense in the Consolidated Statements of Operations and Comprehensive Loss.

 

The fair value of the Note is classified as Level 3 within the fair value hierarchy due to the lack of an active market and reliance on unobservable inputs. The fair value is estimated using a discounted cash flow model based on expected future principal and interest payments, adjusted for expected conversions and the floor price of the conversion feature. The discount rate is based on management’s estimate of rates for similar debt instruments, adjusted for the Company’s credit risk. Changes in key assumptions, including the discount rate or expected conversion, could materially affect the estimated fair value of the convertible notes.

 

Issuance costs of $643,500 were expensed as incurred during the year ended December 31, 2025.

 

In December 2025, a holder of the Initial Note converted $45,319 into 2,000 shares of the Company’s common stock. During the third quarter of 2026, holders of the Note converted an aggregate of $2,275,000 into 236,624 shares of the Company’s common stock.

     
Balance as of January 1, 2026  $7,205,666 
Collateral applied by collateral agent   (4,658,686)
Accrued interest   444,031 
Conversions   (2,275,000)
Change in fair value   (691,664)
Balance as of September 30, 2026  $24,347 

 

 

 

 12 

 

 

On May 22, 2026, the Company and the SPA Buyer entered into a First Amendment to the Original SPA (the “SPA Amendment”) to expand the permitted use of proceeds from future Additional Closings to include (i) general corporate purposes and working capital, (ii) acquisitions, investments, or other strategic transactions, and (iii) other lawful corporate purposes. The SPA Amendment continues to prohibit use of proceeds for repayment of general indebtedness, repurchases of the Company’s securities, payments to related parties, and settlement of litigation matters (other than acquisition-related matters). The Company evaluated the SPA Amendment under ASC 470-50, Debt—Modifications and Extinguishments, and concluded that the amendment did not result in a substantial modification, as it did not change the interest rate, conversion terms, principal amount, or maturity date of the Notes; accordingly, no gain or loss was recognized and the amendment was accounted for prospectively.

 

On July 27, 2026, the Company received a notice of default from the investor stating that the Company owed $6,029,495 in unpaid Alternate Conversion Floor Amounts and that the failure to pay was an event of default under the Note. Following the event of default, the collateral agent exercised its rights of the Security Agreement, took control of the collateral held in the Blocked Custodial Account, realized upon that collateral, and applied approximately $4,658,686 of the proceeds in partial satisfaction of the Company’s obligations under the Note. The investor asserts that approximately $1,370,809 remains owed. The Company and the investor are in discussions to resolve the amounts owed and the Company’s remaining obligations under the Note, including a potential waiver of the approximately $1,370,809 the investor asserts is outstanding.

 

The Company has not recorded a liability for the claimed $1,370,809, as management concluded that a loss is not probable or cannot be reasonably estimated in accordance with ASC 450, Contingencies; the Company believes a loss is reasonably possible, with a range of reasonably possible loss of $0 to $1,370,809.)

 

As of September 30, 2026, the Investor has not waived the event of default. Accordingly, the carrying amount of the Note is classified as a current liability in the accompanying condensed consolidated balance sheet. From July 27, 2026, interest on the Note accrues at the default rate of 18.0% per annum until the default is cured or waived.

 

Note 10     WARRANTS

 

IPO Warrants

 

In connection with the Company’s initial public offering, the Company issued warrants to purchase shares of its Common Stock (the “IPO Warrants”). The IPO Warrants contain exercise price reset provisions whereby the exercise price may be adjusted based on the VWAP of the Common Stock following issuance. In addition, the Company may, subject to holder consent, reduce the exercise price at the discretion of the Board of Directors. The IPO Warrants also provide the Company with redemption rights at a price equal to a multiple of the exercise price upon the satisfaction of certain market-based conditions. Due to the presence of exercise price reset features, discretionary repricing provisions and non-nominal redemption terms, the IPO Warrants do not meet the criteria for equity classification. Accordingly, the IPO Warrants are classified as warrant liabilities and are recorded at fair value at each reporting date, with changes in fair value recognized in earnings.

 

The IPO Warrants are classified as Level 3 within the fair value hierarchy because they are not traded in an active market and their valuation relies on significant unobservable inputs. The fair value of the IPO Warrants is estimated using the Black-Scholes option pricing model, incorporating assumptions regarding the fair value of the Company’s common stock, expected term, expected volatility, risk-free interest rate, dividend yield, and adjustments for exercise price reset and redemption features. The expected term equals the remaining contractual term, as the IPO Warrants are fully vested and exercisable. Expected volatility is based on the historical volatility of a group of comparable publicly traded companies over a period consistent with the expected term. The risk-free interest rate is based on U.S. Treasury yields with maturities consistent with the expected term. The dividend yield is assumed to be zero, as the Company has not historically paid dividends and does not expect to pay dividends for the foreseeable future. Changes in key assumptions could materially affect the estimated fair value of the IPO Warrants.

 

 

 

 13 

 

 

               
    September 30,
2026
  December 31,
2025
Exercise price     57.75       57.75  
Risk free rate     3.72%       3.47%  
Dividend yield     0%       0%  
Expected term (year)     1.40       1.65  
Expected volatility     35.68%       36.67%  

 

The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:

          
   September 30,
2026
  December 31,
2025
    $     $  
Fair value at the beginning of period   25,859    76,847 
Fair value change of warrants included in earnings   (25,859)   (50,988)
Fair value at the end of period   –    25,859 

 

All outstanding warrants to purchase common stock, including the number of shares issuable upon exercise and the applicable exercise price, have been proportionately adjusted to reflect the 1-for-30 reverse stock split effected on July 6, 2026, in accordance with the anti-dilution provisions of the applicable warrant agreements. As of September 30, 2026, on a post-Reverse Stock Split basis, warrants to purchase approximately 66,028 shares of common stock were outstanding, at an adjusted exercise price of $57.75 per share. The following is a summary of the IPO warrant activity:

               
  

Number of

Warrants

  

Average

Exercise Price

  

Weighted

Average

Remaining

Contractual

Term in

Years

 
             
Outstanding and exercisable at January 1, 2026   66,028    57.75    1.62 
Exercised   –           
Granted   –           
Expired   –           
Outstanding and exercisable at September 30, 2026   66,028    57.75    0.87 

 

 

 

 14 

 

 

Note 11     COMMON STOCK

 

The Company is authorized to issue 200,000,000 shares of common stock, par value $0.001 per share.

 

Reverse Stock Split

 

On June 25, 2026, the Company’s Board of Directors approved the Reverse Stock Split, pursuant to stockholder authorization obtained at the Company’s annual meeting held on January 12, 2026. The Reverse Stock Split became effective on July 6, 2026, at which time every 30 shares of common stock issued and outstanding were automatically combined into one share, without any change in par value. Immediately prior to the Reverse Stock Split, the Company had 46,806,289 shares of common stock issued and outstanding, which were reduced to 1,560,210 shares. No fractional shares were issued; holders otherwise entitled to a fractional share received a cash payment in lieu thereof. Proportionate adjustments were made to the exercise prices and number of shares issuable under all outstanding stock options, warrants, and restricted stock units, as well as shares reserved under the Company’s equity incentive plans. The Reverse Stock Split was undertaken to enable the Company to satisfy the minimum bid price requirement for continued listing on The Nasdaq Capital Market.

 

In accordance with ASC 260, Earnings Per Share, all share and per-share amounts presented in these unaudited condensed consolidated financial statements and accompanying notes for all periods presented have been retroactively adjusted to reflect the Reverse Stock Split.

 

As of September 30, 2026, the Company had 2,396,612 shares of common stock issued and outstanding.

 

Equity Purchase Facility Agreement

 

On May 22, 2026, the Company entered into an Equity Purchase Facility Agreement (“EPFA”) with an institutional investor pursuant to which the Company has the right, but not the obligation, to issue and sell up to $100 million of newly issued shares of common stock (the “Advance Shares”) to the investor over a 24-month commitment period commencing on the EPFA date, at the Company’s sole discretion and without any mandatory minimum amount or non-usage fee.

 

The investor’s ownership is limited to 4.99% of outstanding shares, and increasable to 9.99% upon 61 days’ notice. Absent stockholder approval under Nasdaq rules, aggregate shares issuable under the EPFA may not exceed 19.99% of shares outstanding as of the EPFA date. During the Additional Issuance Restricted Period defined in the EPFA, the investor has a right of first refusal on subsequent placements, and the Company is prohibited from entering into variable rate transaction defined in the EPFA, subject to customary exceptions.

 

The EPFA will terminate upon the earliest of (i) the 24-month anniversary of the EPFA, (ii) the investor’s purchase of Advance Shares equal to the full $100 million commitment, or (iii) a material restatement of the Company’s financial statements for two or more consecutive fiscal quarters.

 

In connection with the EPFA, the Company entered into a Registration Rights Agreement obligating it to file a registration statement with SEC covering resale of the Advance Shares. As of September 30, 2026, the Company had not delivered any advance notice and had not issued any shares or received any proceeds under the EPFA. On July 8, 2026, the Company filed a registration statement on Form S-3 with the SEC to register for resale up to 7,500,000 shares of common stock (representing approximately $15 million based on the closing price on July 7, 2026) issuable under the EPFA.

 

 

 

 

 15 

 

 

Recent Issuance of Common Stock

 

  · In the first quarter of 2026, a preferred stock holder converted 340 shares of preferred stock Series B with $14,241 dividend in exchange of 28,883 shares of common stock.
  · In the second quarter of 2026, a preferred stock holder converted 3,160 shares of preferred stock Series B with $206,893 dividend in exchange of 374,080 shares of common stock.
  · On April 15, 2026, the Company issued 92,333 shares of common stock under the 2018 Stock Option and Award Incentive Plan.
  · On July 9, 2026, a convertible note holder converted $2,275,000 of principal with $139,343 of interest of the convertible note into 236,285 shares of common stock.
  · On July 28, 2026, the Company issued 300,000 shares of common stock to the seller under the QMAX VIE Agreements, with an aggregate fair value of $408,000 described in Note 7.
  · On July 29, 2026, the Company issued 40,000 shares of common stock to Andy Jin and Song-Yuan Teng under the employment agreements described in Note 13.
  · On August 17, 2026, the Company issued 50,000 shares of common stock to Chien-Hua Tseng under the consulting agreement described in Note 13.
  · On August 17, 2026, the Company issued 100,000 shares of common stock to Shun-Chih Chuang under the employment agreements described in Note 13.
  · On August 20, 2026, the Company issued 89,653 shares of common stock under the 2018 Stock Option and Award Incentive Plan.
    On September 3, 2026 the Company issued 20,464 shares of common stock to Phoenix MGMT & Consulting LLC as service rendered.  

 

Note 12     PREFERRED STOCK

 

The Reverse Stock Split described in Note 11 applied only to the Company’s common stock and did not affect the authorized, issued, or outstanding shares of preferred stock.

 

Series A Preferred Stock

 

In August 2021, the Company issued 80,000 shares of Series A preferred stock, par value $0.001 per share (the “Series A Preferred Stock”) at an issue price of $2.50 per share to certain investors. The Series A Preferred Stock is non-voting and non-redeemable. The holder of the Series A Preferred Stock will have priority over the holders of Common Stock of the Company on the assets and funds of the Company in a distribution of assets in the event of a liquidation, winding up or dissolution of the Company.

 

On July 6, 2026, the Company effected a 1-for-30 reverse stock split for each share of Common Stock issued and outstanding. As a result of this reverse stock split, the shares of Common Stock issuable upon the conversion of Series A Preferred Stock decreased from 53,334 shares to 1,778 shares.

 

As of September 30, 2026 and December 31, 2025, there were 80,000 shares of Series A Preferred Stock issued and outstanding.

 

Series B Preferred Stock

 

On August 28, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of Nevada, designating up to 1,000,000 shares of series B preferred stock, par value $0.001 per share (the “Series B Preferred Stock”). Each share of Series B Preferred Stock has a stated value of $1,000.

 

On August 29, 2025, the Company entered into a securities purchase agreement and issued 3,500 shares of Series B Preferred Stock, par value $0.001 per share, to an institutional accredited investor at a purchase price of $910 per share. The aggregate purchase price received by the Company was $2,635,000, net of issuance costs of $550,000.

 

 

 

 16 

 

 

During the first and second quarters of 2026, the holder of the Series B Preferred Stock elected to convert all outstanding shares of Series B Preferred Stock into shares of the Company’s Common Stock at an average conversion price of $0.33 per share, resulting in the issuance of 12,088,869 shares of Common Stock. Following the Company’s 1-for-30 reverse stock split effected on July 6, 2026, the conversion represents 402,963 shares of Common Stock issued at an adjusted conversion price of $9.90 per share. Upon conversion, the $2,635,000 carrying value of the Series B Preferred Stock was derecognized from mezzanine equity, and an aggregate of $2,801,292 was reclassified to Common Stock and additional paid-in capital, including accrued dividends settled in shares. As of September 30, 2026, no shares of Series B Preferred Stock remained outstanding, and all associated rights and preferences had been terminated.

 

Note 13     SHARE-BASED COMPENSATION 

 

In 2018, the Company’s Board of Directors and stockholders adopted the 2018 Stock Option and Award Incentive Plan (the “2018 Plan”). The 2018 Plan provides for the issuance of equity-based awards to employees and non-employee service providers. As of September 30, 2026, 0 shares of Common Stock remained available for future issuance under the 2018 Plan.

 

Executive Compensation

 

On September 2, 2025, the Company entered into a two-year employment agreement with Andy Jin, pursuant to which he serves as the Company’s Chief Executive Officer. The agreement provides an annual base salary of $240,000, and a grant of 600,000 fully vested shares of the Company’s common stock, par value $0.001 per share, issued under the Company’s 2018 Equity Incentive Plan and subject to applicable securities laws. Mr. Jin’s base salary will increase to $600,000 per year upon the occurrence of certain milestones, including (i) the completion of an acquisition, (ii) the Company raising $15 million or more in aggregate capital, (iii) the Company receiving at least $5 million in proceeds from the exercise of its Class B warrants, or (iv) the Company’s common stock closing at or above $2.00 per share on Nasdaq for five consecutive trading days. He is also eligible for discretionary bonuses and to participate in Company benefit programs. The Jin Employment Agreement includes customary confidentiality, intellectual property assignment, non-solicitation, non-disparagement, and termination-for-cause provisions.

 

On August 17, 2026, the Company entered into a two-year employment agreement with Shun-Chih Chuang, the Company’s Chief Financial Officer, providing for an annual salary of $84,000 and the issuance of 100,000 shares of common stock upon execution of the agreement and an additional 100,000 shares on the first anniversary thereof, subject to Mr. Chuang’s continued employment. Share-based compensation expense for the three and nine months ended September 30, 2026 includes $512,000 related to this agreement, measured based on the closing price of the Company’s common stock on the grant date.

 

On September 2, 2025, the Company entered into a two-year with Song-Yuan Teng, pursuant to which he serves as the Company’s Asia Director. The agreement provides an annual base salary of $240,000, and a grant of 600,000 fully vested shares of the Company’s common stock, par value $0.001 per share, issued under the Company’s 2018 Equity Incentive Plan. Mr. Teng’s base salary will increase to $600,000 per year upon the occurrence of certain milestones, including (i) the completion of an acquisition, (ii) the Company raising $15 million or more in aggregate capital, (iii) receipt of at least $5 million in proceeds from the exercise of its Class B warrants, or (iv) the Company’s common stock closing at or above $2.00 per share on Nasdaq for five consecutive trading days. He is also eligible for discretionary bonuses and to participate in Company benefit programs. The Teng Employment Agreement includes customary confidentiality, intellectual property, non-solicitation, non-disparagement, and termination-for-cause provisions.

 

 

 

 

 17 

 

 

Phoenix Advisory Agreement

 

In connection with the Strategic Advisory Agreement (the “Advisory Agreement”) described in Note 17, the Company is obligated to issue $50,000 of restricted common stock to Phoenix MGMT & Consulting LLC (“Phoenix”) per quarter, with the number of shares determined based on the five-day volume-weighted average price (“VWAP”) of the Company’s common stock, issued within 10 business days following the end of each quarter. The Company determined that this award is classified as a liability in accordance with ASC 718, Share-Based Compensation (“ASC 718”), because the award is settled in a variable number of shares with a fixed monetary value. The award is remeasured at fair value at each reporting date, with changes in fair value recognized in general and administrative expenses in the unaudited condensed consolidated statements of operations, until the award is settled through the issuance of shares. The requisite service period for each quarterly award corresponds to the quarter to which the award relates.

 

Under the Advisory Agreement, Phoenix is also entitled to a transaction fee equal to 5% of the value of certain qualifying strategic transactions consummated during the term, payable 50% in cash and 50% in shares of common stock valued based on the five-day VWAP preceding the closing of the applicable transaction. Consistent with the fixed-monetary-value mechanics described above, the stock-settled portion of any such fee, if and when recognized, will be classified as a liability under ASC 718. As of September 30, 2026, no transaction fee had been earned, as no qualifying transaction had been introduced, structured, materially advanced, or consummated during the period.

 

QMAX Consulting Agreement

 

On August 17, 2026, the Company entered into a two-year Consulting Agreement, effective as of that date, with Chien-Hua Tseng, pursuant to which Mr. Tseng provides strategic advisory services relating to artificial intelligence module technology strategy, product roadmap, market positioning, and related corporate decisions. Mr. Tseng is the founder of QMAX. and the counterparty to the Company’s QMAX VIE Agreements. As consideration under the Consulting Agreement, the Company issued Mr. Tseng 50,000 shares of common stock on August 17, 2026, fully vested upon issuance, and 50,000 additional shares are issuable on August 17, 2027 contingent on continued service through that date.

 

Note 14     INCOME TAXES

 

The Company and its subsidiary, and the consolidated VIE file tax returns separately.

 

United States

 

The Company evaluated the Global Intangible Low Taxed Income (“GILTI”) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations. The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI inclusion, which effectively reduces the 21% U.S. corporate tax rate on the foreign income to an effective rate of 10.5%. The GILTI inclusion further provides for a foreign tax credit in connection with the foreign taxes paid.

 

PRC

 

A Wholly Foreign Owned Enterprise and the consolidated VIE established in the PRC are subject to the PRC statutory income tax rate of 25%, according to the PRC Enterprise Income Tax law. The PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in which the loss was incurred.

 

 

 

 18 

 

 

Taiwan

 

The Company’s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred in Taiwan. The statutory income tax rate in Taiwan is 20%. An additional surtax of 5%, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed or set aside as a legal reserve before the end of the following year. The 5% surtax is recorded in the period the income is earned, and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal reserve is finalized in the following year.

 

The components of the income tax (benefit) expense are:

                               
    Three months ended
September 30,
  Nine months ended
September 30,
    2026   2025   2026   2025
    $     $     $     $  
Current     –       (2,870 )     –       (143,431 )
Deferred     –       –       –       –  
Total income tax expense     –       (2,870 )     –       (143,431 )

 

The reconciliation of income taxes expenses computed at the Taiwan statutory tax rate applicable to income tax expense is as follows:

                    
   Nine months ended September 30, 
   2026   2025 
   $   %   $   % 
Taiwan income tax statutory rate   (555,392)   20.0    (358,734)   20.0 
Tax effect of non-deductible expense   220,727    (7.95)   13,978    (0.78)
Tax effect of stock-based compensation   –    –    19,569    (1.09)
Tax effect of non-taxable income   83,492    (3.01)   –    – 
Tax effect of different tax rates in other jurisdictions   869    (0.03)   666    (0.04)
Changes in valuation allowance   237,631    (8.56)   54,537    (3.04)
Others   12,673    (0.46)   413,415    (23.05)
Effective tax rate   –    –    143,431    (8.00)

 

The valuation allowance as of September 30, 2026 and December 31, 2025 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment. The movement for the valuation allowance is as following.

          
  

September 30,

2026

 

December 31,

2025

    $     $  
Balance at beginning of the year   259,745    4,774,396 
Additions of valuation allowance   137,937    – 
Reductions of valuation allowance   –    (4,678,552)
Balance at the end of the period   397,682    95,844 

 

 

 

 19 

 

 

Note 15    RELATED PARTY BALANCES AND TRANSACTIONS

 

The balance due to related parties was as following:

          
   September 30,
2026
  December 31,
2025
    $     $  
Mountain Share Transfer, LLC (1)   7,681    7,681 
Estate of Mr. Yin-Chieh Cheng (2)   17,786    15,884 
    25,467    23,565 

___________________

Note:

 

(1) Mountain Share Transfer, LLC is the Company’s transfer agent and is 100% controlled by Erik S. Nelson, a former corporate secretary and director of the Company. The balances represented the amount previously paid on behalf of the Company for its daily operations.
   
(2) The amount due to Mr. Yin-Chieh Cheng’s estate relates to a prior arrangement with him while he served as a director and executive officer of the Company. Mr. Yin-Chieh Cheng was deceased as of July 8, 2023, and the Company is evaluating settlement with the estate.

 

Note 16    LOSS PER SHARE

 

Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Basic and diluted weighted average shares outstanding for the three and nine months ended September 30, 2026 and 2025 have been retroactively adjusted to reflect the 1-for-30 reverse stock split effected on July 6, 2026. See Note 11. Weighted average shares for the three months ended September 30, 2026 reflect 1,560,210 shares outstanding at July 1, 2026 and shares issued during the quarter weighted by the number of days outstanding. Weighted average shares for the nine months ended September 30, 2026 reflect 481,121 shares outstanding at January 1, 2026 and shares issued during the period weighted by the number of days outstanding; for issuances without a specified date, the Company assumed issuance at the midpoint of the quarter in which they occurred.

 

For the three and nine months ended September 30, 2026 and 2025, the Company reported a net loss from continuing operations attributable to common stockholders. Accordingly, all potential common shares were excluded from the computation of diluted net loss per share because their inclusion would have been anti-dilutive. Basic and diluted net loss per share are therefore identical for all periods presented. The following potential common shares (on a post-reverse-split basis) were excluded from the computation of diluted net loss per share:

          
   September 30,
2026
  September 30,
2025
Series A Preferred Stock   1,778    1,778 
Series B Preferred Stock   –    402,963 
Convertible Note   25,000    – 
Common stock warrants   66,028    66,028 
Contingently issuable common shares   150,000    – 

 

 

 

 20 

 

 

Net loss attributable to common stockholders is calculated as net loss less preferred stock dividends, including dividends declared, accrued, and deemed dividends, if any.

          
   Three months ended September 30,
   2026  2025
    $     $  
Net loss   (1,160,046)   (1,511,650)
Less: Net loss attributable to non-controlling interest   –    (11,235)
Net loss attributable to the Company   (1,160,046)   (1,500,415)
           
Less: Preferred stock dividends          
Series A Preferred Stock – paid, accrued, and deemed dividends   –    – 
Series B Preferred Stock – paid, accrued, and deemed dividends   –    – 
Net loss attributable to common stockholders   (1,160,046)   (1,500,415)
           
Weighted Average Shares Outstanding – Basic and Diluted   2,396,612    478,918 
           
Loss per share – basic and diluted   (0.4840)   (3.1329)

 

                 
    Nine months ended September 30,
    2026   2025
    $     $  
Net loss     (3,975,095 )     (2,095,961 )
Less: Net loss attributable to non-controlling interest     –       (31,772 )
Net loss attributable to the Company     (3,975,095 )     (2,064,189 )
                 
Less: Preferred stock dividends                
Series A Preferred Stock – paid, accrued, and deemed dividends     (70,126 )      –  
Series B Preferred Stock – paid, accrued, and deemed dividends     –       –  
Net loss attributable to common stockholders     (4,045,221 )     (2,064,189 )
                 
Weighted Average Shares Outstanding – Basic and Diluted     2,396,612       478,918  
                 
Loss per share – basic and diluted     (1.6879 )     (4.3101 )

 

 

 

 21 

 

 

Note 17    COMMITMENTS AND CONTINGENCIES

 

Strategic Advisory Agreement

 

On May 18, 2026, the Company entered into the Advisory Agreement with Phoenix, pursuant to which Phoenix provides non-exclusive strategic advisory and execution support services to the Company. The initial term is 90 days, subject to extension by mutual written agreement. Either party may terminate the agreement upon 15 days’ written notice following an uncured material breach by the other party.

 

Under the Advisory Agreement, the Company is obligated to pay Phoenix an initial retainer of $150,000 for the first 30 days, followed by $50,000 per month thereafter, plus $50,000 of restricted common stock per quarter, valued based on the five-day volume-weighted average price prior to issuance. During the three and nine months ended September 30, 2026, the Company incurred $150,000 of cash advisory fees and issued 20,464 shares of restricted common stock. As of September 30, 2026, the Company’s remaining minimum unconditional cash commitment under the Advisory Agreement was approximately $10,000.

 

In addition, the Company has agreed to pay Phoenix a transaction fee equal to 5% of the value of any merger, acquisition, joint venture, or similar transaction consummated during the term that Phoenix introduces, structures, or materially advances, payable 50% in cash and 50% in common stock. No such transaction fee had been earned or was payable as of September 30, 2026, as no qualifying transaction had been introduced or consummated during the period.

 

Lease Commitment

 

The Company has two non-cancelable lease agreements for certain office and accommodation as well as fish farming containers for research and develop advanced technology for water circulation applying in fishery. Future minimum lease payments under non-cancellable operating leases with initial terms within one year. The Company recognizes lease expense on a straight-line basis over the lease term.

 

For the nine months ended September 30, 2026 and 2025, the Company recognized $8,039 lease expense in operating expenses. The total future minimum lease payment under non-cancellable short-term leases as of September 30, 2026 is $12,935.

 

Capital commitments

 

As of September 30, 2026, the Company’s capital commitments contracted but not yet reflected in the consolidated financial statements amounted to $nil.

 

Contingencies

 

In the ordinary course of business, the Company may be subject to legal proceeding regarding contractual and employment relationships and a variety of other matters. The Company records contingent liabilities resulting from such claims when a loss is assessed to be probable and the amount of the loss is reasonably estimable.

 

Other than the notice of default and the disputed amounts claimed under its senior secured convertible note described in Note 9, as to which the Company and the investor are in discussions, the Company is not currently a party to any pending legal proceedings that management believes are material.

 

 

 

 22 

 

 

Note 18     SEGMENT INFORMATION

 

The Company’s Chief Operating Decision Maker (“CODM”) Song-Yuan Teng, who is responsible for reviewing the results of operations and allocating resources across the Company’s reportable segments. During the periods presented, the Company’s reportable segments consisted of Fish Trading and E-Commerce, and in 2026, Electronic Components Trading. These operating segments reflect the manner in which the CODM evaluates performance and allocates resources. Segment general and administrative expenses exclude share-based compensation, which is not allocated to segments.

 

On December 31, 2025, the Company completed the disposal of its Catering segment (Meixin). The results of the Catering segment have been classified as discontinued operations for all periods presented. Accordingly, the segment information disclosed below excludes the results of the Catering segment. The Catering segment reported net sales of $2,418 and $4,507 for the three months and nine months ended September 30, 2025, respectively.


Segment performance is evaluated based on segment revenue and operating profit, which includes direct costs and segment-specific general and administrative expenses, but excludes corporate overhead and interest. The CODM does not regularly review segment assets, and therefore segment asset information is not presented.

  

Summary operating results for each of the Company’s reportable segments were as follows:

                
   Three months ended September 30, 2026 
   Fish Trading   E-Commerce   Electronic Components Trading   Total 
   $   $   $   $ 
Revenue   578,018    22,534    1,554,728    2,155,280 
Cost of revenue   (576,874)   (23,613)   (1,099,931)   (1,700,418)
Gross profit   1,144    (1,079)   454,797    454,862 
General and administrative expenses   (13,439)   (12,733)   (1,320,230)   (1,346,402)
Segment operating losses   (12,295)   (13,812)   (865,433)   (891,540)
Income tax expenses   –    –    –    – 
Segment losses   (12,295)   (13,812)   (865,433)   (891,540)

 

   Three months ended September 30, 2025
   Fish Trading  E-Commerce  Total
    $     $     $  
Revenue   1,430,259    79,712    1,509,971 
Cost of revenue   (1,435,927)   (29,587)   (1,465,514)
Gross profit   (5,668)   50,125    44,457 
General and administrative expenses   (780,241)   (28,137)   (808,378)
Segment operating losses   (785,909)   21,988    (763,921)
Income tax expenses   (2,870)   –    (2,870)
Segment losses   (788,779)   21,988    (766,791)

 

 

 

 23 

 

                 
   Nine months ended September 30, 2026 
   Fish Trading   E-Commerce   Electronic Components Trading   Total 
   $   $   $   $ 
Revenue   4,914,123    103,777    1,554,728    6,572,628 
Cost of revenue   (4,904,363)   (53,494)   (1,099,931)   (6,057,788)
Gross profit   9,760    50,283    454,797    514,840 
General and administrative expenses   (75,502)   (35,316)   (2,446,275)   (2,557,093)
Segment operating losses   (65,742)   14,967    (1,991,478)   (2,042,253)
Income tax expenses   –    –    –    – 
Segment losses   (65,742)   14,967    (1,991,478)   (2,042,253)

          
   Nine months ended September 30, 2025
   Fish Trading  E-Commerce  Total
    $     $     $  
Revenue   7,408,539    121,399    7,529,938 
Cost of revenue   (7,378,382)   (29,729)   (7,408,111)
Gross profit   30,157    91,670    121,827 
General and administrative expenses   (1,230,903)   (38,126)   (1,269,029)
Segment operating losses   (1,200,746)   53,544    (1,147,202)
Income tax expenses   (143,431)   –    (143,431)
Segment losses   (1,344,177)   53,544    (1,290,633)

 

The following table summarizes revenue disaggregated by primary geographical market based on destination of shipment for products:

    
Geographic Information    
   Nine months ended September 30, 2026 
   $ 
Taiwan   3,797,944 
Japan   2,670,907 
Other foreign countries   103,777 
Total   6,572,628 

 

 

 

 

 24 

 

 

Note 19     SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

  

Preferred Stock Dividend Payable

 

During the nine months ended September 30, 2026, the Company accrued dividends of $221,134 on the Series B Preferred Stock were settled in shares of common stock in connection with the conversion of all outstanding Series B Preferred Stock. During 2025 and 2024, the Company declared preferred stock dividends of $16,000 each year on its Series A Preferred Stock, which were not paid in cash but recorded as an increase in dividends payable. As of September 30, 2026 and December 31, 2025, unpaid preferred dividends totaled $70,312 and $177,326, respectively, as reflected in dividend payable on the condensed consolidated balance sheets.

 

These transactions did not involve the use of cash and, therefore, are not reflected in the accompanying Consolidated Statement of Cash Flows.

 

Note 20     SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the date the condensed consolidated financial statements were issued and, other than as disclosed elsewhere in these notes, has identified no subsequent events requiring recognition or disclosure.

 

 

 

 

 

 

 

 

 

 

 

 

 

 25 

 

 

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF OPERATING AND FINANCIAL RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q. Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). This discussion contains forward-looking statements and actual results could differ materially from those projected in the forward-looking statements. For additional information regarding these and other risks and uncertainties, please see the items listed under the section captioned “Cautionary Statement Regarding Forward-Looking Statements” herein as well as any other cautionary language and risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 15, 2026, as amended on April 21, 2026 and August 28, 2026. Except as may be required by law, we undertake no obligation to update any forward-looking statement to reflect events after the date of this Quarterly Report on Form 10-Q.

 

Operations Overview

 

Our business operations consist primarily of our Fish Trading and E-Commerce segments, which are administered through NTB and Xinca, respectively. In addition, in 2025, the Company made substantial equity investments in two e-commerce companies, one based in the United States and the other in France, and we maintain a legacy RAS design and consulting business. Beginning in the third quarter of 2026, the Company commenced its Electronic Components Trading business, initially focusing on memory products and intending to expand into additional electronic components and semiconductor-related products as market opportunities develop.

 

Recent Developments

 

On July 27, 2026, the Company received a notice of default from the holder of its $8.0 million senior secured convertible note, asserting $6,029,495 in unpaid Alternate Conversion Floor Amounts. Following the event of default, the collateral agent seized control of the Company’s blocked custodial account and applied approximately $4.7 million of the proceeds against amounts claimed under the note. The holder asserts approximately $1.4 million remains outstanding. The Company is in discussions with the holder regarding the remaining claimed amounts, including a potential waiver. See Note 9 to the condensed consolidated financial statements.

 

On July 28, 2026, the Company entered into a series of agreements (collectively, the “QMAX VIE Agreements”) with QMAX, a company registered in Taiwan that provides memory and storage solutions, and with the holder of 30% of QMAX’s equity (the “Seller”). The QMAX VIE Agreements consist of a voting proxy, an equity pledge, an exclusive call option and an exclusive business cooperation agreement, each with a ten-year term and terminable only by the Company. Pursuant to the QMAX VIE Agreements, the Company obtained voting rights and economic rights with respect to the Seller’s 30% equity interest in QMAX. The consideration transferred consisted of 300,000 shares of the Company’s common stock with an aggregate fair value of $408,000. The Seller remains the registered legal owner of the equity interest, and no transfer of registered legal title was effected. The Company has determined that QMAX is a variable interest entity and that the Company is not its primary beneficiary. Through its rights with respect to the Seller’s 30% equity interest, the Company has the ability to exercise significant influence, but not control, over QMAX’s operating and financial policies, and accounts for its investment under the equity method. See Note 7 to the condensed consolidated financial statements.

 

On July 28, 2026, the Company received a letter from The Nasdaq Stock Market LLC confirming that the Company had regained compliance with the minimum bid price requirement for continued listing. On August 10, 2026, the Company received a letter from Nasdaq confirming that the Company had regained compliance with the stockholders’ equity requirement, closing the matter raised in Nasdaq’s April 17, 2026 notification letter.

 

On August 7, 2026, the Company completed the sale of approximately 231 acres of land in Montgomery County, Alabama for $700,000 in cash, recognizing a loss on sale of approximately $178,000. Net cash proceeds after settlement charges were approximately $654,604. See Note 5 to the condensed consolidated financial statements.

 

On August 17, 2026, the Company appointed Shun-Chih Chuang as Chief Financial Officer and entered into a two-year employment agreement with Mr. Chuang. See Note 13 to the condensed consolidated financial statements.

 

 

 

 26 

 

 

On September 17, 2026, the Company entered into a Strategic Partnership and Joint Distribution Agreement (the “E-PRO Agreement”) with E-PRO DISPLAY CO., LTD. (“E-PRO”), a Taiwan company, under which E-PRO appointed the Company as a non-exclusive, worldwide distributor of pre-owned iPhone 17 Pro and iPhone 17 Pro Max handsets under a buy-back and trade-in program operated by iFP Green Technology Limited and its affiliates (“iFP”). E-PRO holds exclusive distribution rights from iFP with respect to goods allocated to E-PRO under the program, and the Company is responsible for sales, customer development, and channel building. No revenue was recognized under the E-PRO Agreement during the quarter ended September 30, 2026.

 

Restatement of Previously Issued Financial Statements

 

On August 14, 2026, the Board of Directors of the Company, after discussion with management and in consultation with the Company’s independent registered public accounting firm, concluded that the Company’s previously issued consolidated financial statements for the fiscal years ended December 31, 2024 and December 31, 2025, as included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed April 15, 2026, as amended on April 21, 2026, and the Company’s unaudited interim condensed consolidated financial statements for the quarterly periods ended March 31, 2025, June 30, 2025, and September 30, 2025, should no longer be relied upon due to errors identified in those financial statements. The Company filed Amendment No. 2 to its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025 on August 28, 2026.

 

Key Factors Affecting our Performance

 

As a result of a number of factors, our historical results of operations may not be comparable to our results of operations in future periods, and our results of operations may not be directly comparable from period to period. Set forth below is a brief discussion of the key factors impacting our results of operations.

 

As part of our long-term growth strategy, we may allocate capital toward selective acquisitions or strategic investments that we believe could enhance our operating platform and diversify our revenue base. We intend to evaluate potential targets based on financial performance, scalability, regulatory considerations, and strategic alignment with our core competencies. Any acquisition would be subject to due diligence, negotiation of definitive agreements, availability of financing, and applicable regulatory approvals. Acquisitions involve inherent risks, including integration challenges, potential dilution, assumption of liabilities, and diversion of management attention. There can be no assurance that any contemplated transaction will be identified or consummated, or that any completed transaction will achieve the anticipated benefits.

 

Known Trends and Uncertainties

 

Inflation

 

Prices of certain commodity products, including raw materials, are historically volatile and are subject to fluctuations arising from changes in domestic and international supply and demand, labor costs, competition, market speculation, government regulations, trade restrictions and tariffs. Increasing prices in the component materials for our goods may impact the availability, the quality and the price of our products, as suppliers search for alternatives to existing materials and increase the prices they charge. Our suppliers may also fail to provide consistent quality of products as they may substitute lower cost materials to maintain pricing levels. Nocera’s cost base also reflects significant elements for freight, including fuel, which has significantly increased due to the effects of the coronavirus (COVID-19) pandemic, the Russia-Ukraine war and the conflicts in the Middle East. Rapid and significant changes in commodity prices such as fuel and plastic may negatively affect our profit margins if Nocera is unable to mitigate any inflationary increases through various customer pricing actions and cost reduction initiatives.

 

 

 

 27 

 

 

Geopolitical Conditions

 

Our operations could be disrupted by geopolitical conditions, trade disputes, international boycotts and sanctions, political and social instability, acts of war, terrorist activity or other similar events. From time to time, we could have a large revenue stream associated with a particular customer or a large number of customers located in a particular geographic region. Decreased demand from a discrete event impacting a specific customer, industry or region in which we have a concentrated exposure could negatively impact our results of operations.

 

In February 2022, Russia initiated significant military action against Ukraine. In response, the U.S. and certain other countries imposed significant sanctions and export controls against Russia, Belarus and certain individuals and entities connected to Russian or Belarusian political, business and financial organizations, and the U.S. and certain other countries could impose further sanctions, trade restrictions and other retaliatory actions should the conflict continue or worsen. It is not possible to predict the broader consequences of the conflict, including related geopolitical tensions and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof as well as any counter measures or retaliatory actions by Russia or Belarus in response, including, for example, potential cyberattacks or the disruption of energy exports, is likely to cause regional instability, geopolitical shifts and could materially adversely affect global trade, currency exchange rates, regional economies and the global economy. The situation remains uncertain, and while it is difficult to predict the impact of any of the foregoing, the conflict and actions taken in response to the conflict could increase our costs, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition and results of operations.

 

Foreign Currency

 

Our reporting currency is the U.S. dollar and our operations in Taiwan use their local currency as their functional currencies. Substantially all of our revenue and expenses are in NT dollars. We are subject to the effects of exchange rate fluctuations with respect to any of such currency. For example, the value of the NT dollar depends to a large extent on Taiwan government policies and Taiwan’s domestic and international economic and political developments, as well as supply and demand in the local market.

 

The income statements of our operations are translated into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar strengthens against foreign currencies, the translation of these foreign currencies denominated transactions results in reduced revenue, operating expenses and net income for our international operations. We are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries into U.S. dollars in consolidation.

  

Critical Accounting Policies, Estimates and Assumptions

 

We prepare our financial statements in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the financial reporting period. We continually evaluate these estimates and assumptions based on the most recently available information, our own historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application.

 

Our critical accounting policies and estimates are described in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 15, 2026, as amended on April 21, 2026 and August 28, 2026. Except for the newly adopted accounting policy related to our investments in crypto assets during the first quarter of 2026, there have been no material changes to our critical accounting policies and estimates since December 31, 2025.

 

 

 

 28 

 

 

Results of Operations

 

The following table sets forth the consolidated statements of operations of the Company for the three and nine months ended September 30, 2026 and 2025.

 

Consolidated Statements of Operations

                 
   Three months ended
September 30,
   Nine months ended
September 30,
 
   2026   2025   2026   2025 
   (Unaudited)   (As Restated)   (Unaudited)   (As Restated) 
   $   $   $   $ 
Net sales   2,155,280    1,509,971    6,572,628    7,529,938 
Cost of sales   (1,700,418)   (1,465,514)   (6,057,788)   (7,408,111)
Gross profit   454,862    44,457    514,840    121,827 
                     
Operating expenses                    
General and administrative expenses   (1,346,402)   (808,378)   (2,557,093)   (1,269,029)
Share based compensation   (181,996)   –    (783,086)   – 
Total operating expenses   (1,528,398)   (808,378)   (3,340,179)   (1,269,029)
                     
Loss from operations   (1,073,536)   (763,921)   (2,825,339)   (1,147,202)
                     
Other expense   (86,510)   (688,687)   (1,149,756)   (646,468)
Net loss before income taxes   (1,160,046)   (1,452,608)   (3,975,095)   (1,793,670)
Income tax expense   –    (2,870)   –    (143,431)
Net loss from continuing operations   (1,160,046)   (1,455,478)   (3,975,095)   (1,937,101)
                     
Net loss from discontinued operations   –    (56,172)        (158,860)
Net Loss   (1,160,046)   (1,511,650)   (3,975,095)   (2,095,961)
Less: Preferred dividend   –    –    (70,126)     
Less: Net loss attributable to non-controlling interests   –    (11,235)   –    (31,772)
Net loss attributable to the common stockholders   (1,160,046)   (1,500,415)   (4,045,221)   (2,064,189)
                     
Comprehensive loss                    
Net loss   (1,160,046)   (1,511,650)   (3,975,095)   (2,095,961)
Foreign currency translation gain   24,675    1,111    28,615    46,983 
Total comprehensive loss   (1,135,371)   (1,510,539)   (3,946,480)   (2,048,978)
                     
Less: comprehensive loss attributable to non-controlling interest   –    (11,235)   –    (31,772)
Less: Foreign currency translation (loss) gain attributable to noncontrolling interest   –    (719)   –    2,301 
Comprehensive loss attributable to the Company   (1,135,371)   (1,498,585)   (3,946,480)   (2,019,507)
                     
Loss per share – basic and diluted   (0.4840)   (3.1329)   (1.6879)   (4.3101)
Net loss per share from continuing operations – basic and diluted   (0.4840)   (3.0156)   (1.6879)   (3.9784)
Net loss per share from discontinued operations – basic and diluted   –    (0.1173)   –    (0.3317)
                     
Weighted average number of common shares outstanding – basic and diluted *   2,396,612    478,918    2,396,612    478,918 

 

*Weighted average shares outstanding and net loss per share for all periods presented have been retroactively adjusted to reflect the 1-for-30 reverse stock split effected on July 6, 2026.

 

 

 

 29 

 

 

Comparison of Results of Operations for the three months and nine months ended September 30, 2026 and 2025

 

Revenue

 

Revenue for the three months ended September 30, 2026 and 2025 was approximately $2.2 million and $1.5 million, respectively. The increase in revenue was primarily attributable to revenue generated from the Company’s new electronic components trading business, partially offset by a decline in revenue generated from the Company’s fish trading business.

 

Revenue for the nine months ended September 30, 2026 and 2025 was approximately $6.6 million and $7.5 million, respectively. The decrease in revenue was primarily attributable to a decline in revenue generated from the Company’s fish trading business, partially offset by revenue from the Company’s electronic components trading business.

  

  · Fish Trading Business: For the nine months ended September 30, 2026, both the volume and the average selling price of the fish trading business decreased compared to the comparable period in 2025. Volume decreased from 471 tons to 309 tons and the average selling price of eels decreased from $16.01 to $15.88 per kilogram.

 

Gross profit

 

Gross profit for the three months ended September 30, 2026 and 2025 was approximately $455 thousand and $44 thousand, respectively. The increase in gross profit was primarily attributable to gross profit generated by the Company’s electronic components trading business.

 

Gross profit for the nine months ended September 30, 2026 and 2025 was approximately $515 thousand and $122 thousand, respectively. The increase in gross profit was primarily attributable to gross profit generated by the Company’s electronic components trading business.

 

General and administrative expenses

 

General and administrative expenses for the three months ended September 30, 2026 and 2025 were approximately $1,346 thousand and $808 thousand, respectively. The increase was primarily attributable to costs of wages and reimbursement fees for employees and fees under the Company’s advisory agreement with Phoenix. Share-based compensation was approximately $182 thousand for the three months ended September 30, 2026, compared to nil for the same period in 2025..

 

General and administrative expenses for the nine months ended September 30, 2026 and 2025 were approximately $2,557 thousand and $1,269 thousand, respectively. The increase was primarily attributable to costs of wages and reimbursement fees for employees. Share-based compensation was approximately $783 thousand for the nine months ended September 30, 2026, compared to nil for the same period in 2025.

 

Other expense

 

Other expense for the three months ended September 30, 2026 and 2025 was approximately $86 thousand and $689 thousand, respectively. The decrease was primarily attributable to lower fair value and interest charges on the convertible note following the application of collateral and conversions during the quarter, together with income of approximately $56 thousand from the Company’s equity method investments in QMAX and Tachyonext, partially offset by the loss of approximately $223 thousand on the disposal of property and equipment, including the sale of the Alabama land.

 

Other expense for the nine months ended September 30, 2026 and 2025 was approximately $1,150 thousand and $646 thousand, respectively. The increase was primarily attributable to unrealized losses of approximately $481 thousand on digital assets, non-cash interest expense of approximately $331 thousand on the convertible note, and the loss of approximately $223 thousand on the disposal of property and equipment, including the sale of the Alabama land, partially offset by lower losses from equity method investments.

 

 

 

 30 

 

 

Summary of Consolidated Statements of Cash Flows

  

Nine months ended

September 30,

 
   2026   2025 
   (Unaudited)   (As Restated) 
   $   $ 
Net cash used in operating activities   (2,471,276)   (1,113,102)
Net cash used in investing activities   (4,481,886)   (135,942)
Net cash (used in) provided by financing activities   (5,767)   2,870,824 
Effect of the exchange rate change on cash   27,438    (71,736)
Net (decrease) increase in cash and cash equivalents   (6,931,491)   (1,550,044)

 

Net cash used in operating activities

 

Net cash used in operating activities was approximately $2,471 thousand for the nine months ended September 30, 2026. This was primarily attributable to a net loss of approximately $3,940 thousand, adjusted for non-cash items or non-operating activity, including an approximately $331 thousand of non-cash interest expense on the convertible note, approximately $481 thousand of unrealized losses on digital assets, and approximately $1,243 thousand in share-based compensation expense, and an increase in advances to suppliers of approximately $798 thousand.

 

Net cash used in operating activities was approximately $1,113 thousand for the nine months ended September 30, 2025. This was primarily attributable to a net loss of approximately $2,096 thousand, adjusted for non-cash items or non-operating activity, including an approximately $315 thousand loss on the equity method investment and an approximately $451 thousand loss on warrant liabilities.

 

Net cash used in investing activities

 

Net cash used in investing activities was approximately $4,482 thousand for the nine months ended September 30, 2026, which was primarily attributable to increase in refundable deposits.

 

Net cash used in investing activities was approximately $135 thousand for the nine months ended September 30, 2025, which was primarily attributable to the acquisition of an equity method investment, partially offset by proceeds from the disposal of a subsidiary. .

 

Net cash (used in) provided by financing activities

 

Net cash used in financing activities was approximately $6 thousand for the nine months ended September 30, 2026. This was primarily attributable to the payment of lease liabilities.

 

Net cash provided by financing activities was $2,871 thousand for the nine months ended September 30, 2025. This was primarily attributable to proceeds from issuance of preferred stock and common stock.

 

 

 

 31 

 

 

Liquidity and Capital Resources; Going Concern

 

As of September 30, 2026, we had cash and cash equivalents of $1,020,689, compared to $7,952,180 as of December 31, 2025, and working capital of approximately $1.7 million. We incurred net losses of $1,160,046 and $3,975,095 for the three and nine months ended September 30, 2026, respectively, and had an accumulated deficit of $30,163,566 as of September 30, 2026. These factors, together with the notice of default under our senior secured convertible note and the noteholder’s assertion that approximately $1,370,809 remains outstanding, raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. See Note 1 and Note 9 to the condensed consolidated financial statements. Following the event of default, interest on the note accrues at the default rate of 18.0% per annum until cured or waived, and the collateral agent applied approximately $4,658,686 from our blocked custodial account. Our ability to fund operations over the next 12 months depends on our ability to resolve the amounts claimed under the note and to raise additional capital, including through the EPFA, which is subject to an exchange cap of 19.99% of our shares outstanding on the EPFA date absent stockholder approval and to the effectiveness of a resale registration statement. There can be no assurance that such financing will be available on acceptable terms, or at all.

 

  · On May 22, 2026, the Company entered into an Equity Purchase Facility Agreement, or an EPFA, providing the Company the right, but not the obligation, to sell up to $100 million of common stock to an institutional investor over a 24-month period, subject to customary conditions, ownership limitations, and an exchange cap described in Note 11 to the condensed consolidated financial statements. As of September 30, 2026, the Company had not issued any shares or received any proceeds under the EPFA.

 

Recently Issued Accounting Pronouncements

 

Please refer to Note 1 to the financial statements contained herein.

 

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company,” as defined by Rule 12b-2 of the Exchange Act, we are not required to provide the information in this Item.

 

ITEM 4.    CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer performed an evaluation (the “Evaluation”) of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide a reasonable level of assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that Evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2026, due to the presence of material weaknesses described below, our disclosure controls and procedures were not effective.

 

 

 

 32 

 

 

The following material weaknesses in our disclosure controls and procedures at September 30, 2026 were:

 

  · we did not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act of 2002;
     
  · there were insufficient monitoring and review controls over the financial reporting closing process, including the lack of individuals with current knowledge of GAAP that led to the restatement of our previously issued financial statements; and
     
  · inadequate segregation of duties.

 

We believe that these material weaknesses primarily relate, in part, to our lack of sufficient staff with appropriate training in GAAP and SEC rules and regulations with respect to financial reporting functions, and the lack of robust accounting systems, as well as the lack of sufficient resources to hire such staff and implement these accounting systems.

 

We expect to remediate these material weaknesses in the second half of 2026. However, we may discover additional material weaknesses that may require additional time and resources to remediate. Our remediation process includes, but is not limited to:

 

  · Investing in information technology systems to enhance our operational and financial reporting and internal controls.
     
  · Enhancing the organizational structure to support financial reporting processes and internal controls.
     
  · Providing guidance, education and training to employees relating to our accounting policies and procedures.
     
  · Further developing and documenting detailed policies and procedures regarding business processes for significant accounts, critical accounting policies and critical accounting estimates.
     
  · Establishing effective general controls over information technology systems to ensure that information produced can be relied upon by process level controls is relevant and reliable.

 

Notwithstanding the foregoing, there can be no assurance that our disclosure controls and procedures will detect or uncover all failures of persons within our Company and our consolidated subsidiaries to disclose material information otherwise required to be set forth in our periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended September 30, 2026, we took several actions to correct past material weaknesses, including, but not limited to, establishing an audit committee of our Board comprised of three independent directors, adding experienced accounting and financial personnel and retaining third-party consultants to review our internal controls and recommend improvements. However, we may need to take additional measures to fully mitigate these issues, and the measures we have taken, and expect to take, to improve our internal controls may not be sufficient to (1) address the issues identified, (2) ensure that our internal controls are effective or (3) ensure that the identified material weakness or other material weaknesses will not result in a material misstatement of our annual or interim financial statements.

 

 

 

 33 

 

 

PART II OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may be involved in legal proceedings arising in the ordinary course of business. On July 27, 2026, we received a notice of default from the holder of our senior secured convertible note, and the holder asserts that approximately $1,370,809 remains outstanding following the collateral agent’s application of approximately $4,658,686 from our blocked custodial account. We are in discussions with the holder regarding these amounts, and no legal proceeding has been commenced as of the date of this report. See Part II, Item 3 and Note 9 to the condensed consolidated financial statements. Other than the foregoing, we are not currently a party to any legal proceedings that we believe could have a material adverse effect on our business, financial condition or operating results.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes in our risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 15, 2026, as amended on August 28, 2026, except as set forth below.

 

We have recently regained compliance with Nasdaq’s continued listing requirements, but there can be no assurance that we will maintain compliance, and our securities may be delisted if we fail to do so.

 

On April 17, 2026, we received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that we did not meet the minimum stockholders’ equity requirement of $2.5 million for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). On August 10, 2026, Nasdaq notified us that we had regained compliance with that requirement, and on July 28, 2026, Nasdaq confirmed that we had regained compliance with the minimum bid price requirement following the Reverse Stock Split. Our stockholders’ equity was $7,654,512 as of September 30, 2026. However, we continue to incur net losses, and any further decline in stockholders’ equity, or a failure to maintain a minimum bid price of $1.00 per share, could result in a new deficiency. Because we effected a reverse stock split within the prior one-year period, under Nasdaq Listing Rule 5810(c)(3)(A)(iv) we may not be eligible for a compliance period if we again fail to satisfy the minimum bid price requirement, and Nasdaq may proceed directly to delisting determination.

 

If our common stock is delisted, it could adversely affect the liquidity and market price of our securities, limit our ability to access capital markets, including under the EPFA, and negatively impact our business, financial condition, and results of operations.

 

We are in default under our senior secured convertible note, and the exercise of remedies by the noteholder could materially and adversely affect our liquidity and our ability to continue as a going concern.

 

On July 27, 2026, the holder of our senior secured convertible note delivered a notice of default asserting $6,029,495 in unpaid Alternate Conversion Floor Amounts. The collateral agent took control of our blocked custodial account and applied approximately $4,658,686 against amounts claimed, and the holder asserts that approximately $1,370,809 remains outstanding. The holder has not waived the event of default, and interest accrues at the default rate of 18.0% per annum. The note is secured by assets acquired with its proceeds, and the holder may pursue further remedies, including litigation or foreclosure on remaining collateral. We may not be able to reach an agreement with the holder on acceptable terms, or at all. In addition, our management has concluded that there is substantial doubt about our ability to continue as a going concern.

 

 

 

 34 

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the quarter ended September 30, 2026, the Company issued the following shares of common stock in transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”): (i) 300,000 shares to the Seller under the QMAX VIE Agreements on July 28, 2026, as consideration for the rights described in Note 7, in reliance on Regulation S and/or Section 4(a)(2) of the Securities Act; (ii) 50,000 shares to Chien-Hua Tseng on August 17, 2026 as consideration for services under a consulting agreement, in reliance on Section 4(a)(2) of the Securities Act; (iii) 100,000 shares to Shun-Chih Chuang on August 17, 2026 pursuant to his employment agreement, in reliance on Section 4(a)(2) of the Securities Act; and (iv) 20,464 shares of restricted common stock to Phoenix MGMT & Consulting LLC on September 3, 2026 as consideration for advisory services, in reliance on Section 4(a)(2) of the Securities Act. No underwriters were involved in these issuances and no commissions were paid.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

On July 27, 2026, the Company received a notice of default from the holder of its senior secured convertible note in the original principal amount of $8,000,000, asserting $6,029,495 in unpaid Alternate Conversion Floor Amounts and that the failure to pay constituted an event of default under the note. Following the event of default, the collateral agent exercised its rights under the related security agreement, took control of the collateral held in the Company’s blocked custodial account and applied approximately $4,658,686 of the proceeds in partial satisfaction of the amounts claimed under the note. The holder asserts that approximately $1,370,809 remains outstanding. The Company is in discussions with the holder regarding the remaining claimed amounts, including a potential waiver thereof. See Note 9 to the condensed consolidated financial statements.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 Trading Arrangements

 

During the quarter ended September 30, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 

 35 

 

 

ITEM 6. EXHIBITS

 

(a) The following exhibits are filed herewith or incorporated by reference herein:

 

Exhibit No.   Description
     
31.1   Rule 13a-14(a)/15d-14(a) Certification of the President and Chief Executive Officer of Nocera, Inc.*
31.2   Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of Nocera, Inc.*
32.1   Section 1350 Certification of the President and Chief Executive Officer of Nocera, Inc.**
32.2   Section 1350 Certification of the Chief Financial Officer of Nocera, Inc.**
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) *
101.SCH   Inline XBRL Taxonomy Extension Schema Document *
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document *
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document *
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). *

___________________________

*

**

Filed herewith.

Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, except as otherwise specifically stated in such filing.

 

 

 

 

 

 36 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  NOCERA, INC.
     
Date: November 16, 2026 By: /s/ Andy Ching-An Jin                            
  Name: Andy Ching-An Jin
  Title: Chief Executive Officer
    (Principal Executive Officer)
     

 

Date: November 16, 2026 By: /s/ Shun-Chih Chuang                            
  Name: Shun-Chih Chuang
  Title: Chief Financial Officer
    (Principal Financial Officer)
    (Principal Accounting Officer)

 

 

 

 

 

 

 

  

 

 

 

 37 

 

Keep reading